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    INTRODUCTION 
 
In the view of Siddhar Thirumoolar definition of medicine, that one who ensures 
ailments of physical, mental, preventive and also postpone the death. Siddha system of 
medicine is a unique traditional system of medicine in the world. It is also called Tamil 
Maruthuvam and commonly followed by Tamil people since time immemorial. According to 
Siddha system of medicine, perfect health is maintained by three uyirthathukkal (humours) 
namely Vaatham, Pitham, Kabam. Whenever there is derangement in these three 
uyirthathukkal, the resultant will be diseases. The salvation is the ultimate aim of Siddhars, 
so they are maintained their health physically and mentally. 
Siddha system has the wonderful principle which is Panchapootham theory. 
According to Panchapootham theory the universe and the human body both are formed by 
five elements i.e. Space, Air, Fire, Water, and Earth. Likewise, the diseases and the medicines 
are also based on the Panchapootham theory. Siddhars believed in the concept that a healthy 
soul can developed only from a healthy body. So, they developed methods and medications 
to strengthen their physical body and thereby their souls. 
Siddhars have listed the diseases of mankind as 4448 based on the Mukkutram i.e., Vali, 
Azhal, Iyyam. Among the 4448 diseases, the Psychological related diseases are classified into 
18 varieties by Siddhar Agasthiyar. The other imperative Siddhars Yugi Munivar and Theraiyar 
have also described the psychiatric diseases in their texts. 
The dissertation topic chosen by me Viyagula Unmatham which mostly correlated with 
the symptoms of Depression in Modern science. 
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     “
 
Depression is a common mental disorder, characterised by sadness, loss of interest or 
pleasure, feeling guilt or low self-esteem, disturbed sleep, appetite, lethargy and poor 
concentration. A depressive disorder is a syndrome that reflects a sad and irritable mood 
exceeding normal sadness or grief. More specifically, the sadness mentality is characterized by 
a greater intensity, duration with severe symptoms and functional disabilities than normal. 
 In this condition, anxiety and depression due to lack of courage, sorrow, grief, paleness, 
loss of wealth and crying with tears are the symptoms of the diseases. 
Depressive disorders are a huge public-health problem, due to its affecting millions of 
people. About 10% of adults up to 8% of teens and 2% of preteen children experience some 
kind of depressive disorder. 
                 Ref: http://www.medicinenet.com/depression/article.htm  
It is the most common psychiatric disorder; its life time prevalence is 17%. It is twice 
as prevalent in women as in men and the mean age of onset is around 40 years. It is commonly 
in divorced and separated persons. 
Depression is also responsible for maximum DAILYs (disability adjusted life years) 
amongst all the psychiatric disorders. It is also the most common cause of suicide. 
Ref: Review of psychiatry_praveen Tripathi 
A large population-based study from India to report on prevalence of depression and 
shows that among urban south Indians, the prevalence of depression was 15.1%. Age, female 
gender and lower socio-economic status are some of the factors associated with depression in 
this population. The overall prevalence of depression was 15.1% (age-adjusted, 15.9%) and 
was higher in females (females 16.3% vs. males 13.9%, p<0.0001). The odds ratio (OR) for 
depression in female subjects was 1.20 [Confidence Intervals (CI): 1.12–1.28, p<0.001] 
compared to male subjects. Depressed mood was the most common symptom (30.8%), 
followed by tiredness (30.0%) while more severe symptoms such as suicidal thoughts (12.4%) 
and speech and motor retardation (12.4%) were less common.    
       Ref: http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007185 
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Yogam is a complete science of health, which deals with understanding of adequate 
functioning of all systems of the body and appropriate coordination between them, along with 
healthy functioning of our mind. The practice of yogam integrated the body with the mind and 
mind with the soul. Yogam prevents one from physical, mental and emotional imbalances due 
to various reasons in our day to day life. Yogam has the capacity to free the body from most of 
the diseases, it not only operates on the physical level but also had great benefits on mental 
worries and tensions. The Pranayamam helps to reduce the intensity of mental stress.   
Every month, about 30-40 patients report to OPD of Ayothidoss Pandithar Hospital, 
National Institute of Siddha, Tambaram sanatorium, Chennai-47.  
  Even though there are vast collection of medicines in Siddha to treat the Mana noigal 
but there is very minimum number of research has been carried out on depression. So, the 
author chosen Thirutharakchatha chooranam internally and Aruganver thylam externally, the 
ingredients are perfect combination for to treat Viyagula unmatham, cost effective and easily 
can be prepared too.  Yogam therapy is indicated for udal and ulanoigal.  Hence the Yogam 
therapy also included in the study.   
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            AIM AND OBJECTIVES  
AIM:    
To comparative clinical study of THIRUTHARAKCHATHA CHOORANAM (internally) 
and ARUGAN VER THYLAM  (externally) with and without yogam therapy. 
 OBJECTIVE:    
➢ To make a detailed clinical evaluation of the disease by careful examination of 
etiology, symptoms, complication, treatment and Prognosis  
➢ To study the Siddha and Modern aspects of Viyagula unmatham (Depression)  
➢ To study the Siddha basic principles towards the efficacy of trial medicines.  
➢ To carry out the Biochemical analysis of trial medicine THIRUTHARAKCHATHA 
CHOORANAM 
➢ To analyse the therapeutical efficacy of trial medicine (internal medicine) of 
THIRUTHARAKCHATHA CHOORANAM for depression. 
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          SIDDHA ASPECT 
 
 In Siddha system, all psychiatric diseases are coming under the kirigai noigal. Kirigai 
maruthuvam, the psychiatry in Siddha system of medicine is propounded by several Siddhars 
of whom the most renowned are AGATHIYAR, YUGIMUNIVAR and THERAIYAR. Their 
descriptions are phenomenological. In Siddha system, the physiology of human body is dealt 
in 96 thatthuvangal (philosophy). Of the 96 thatthuvam, Manam (mind), Buththi (wisdom, 
decision making), Chittham(determination), Agangaram (accomplishment) are the responsible 
for the mental well-being. Agangaram is the innate character of manam. Manam(mind) is 
responsible for thinking, reasoning, planning and self-realization.  
  The mind and physique are inseparable and inter dependable. Manam is both receptive 
and executive. In-appropriate food, seasonal variations, somatic diseases, and drug abuse are 
some of the factors that influence the mind. This stimulates the three humours vali, azhal and 
iyam, especially deranges vali or azhal or often the predominance of azhal humour over the 
other two, thereby manifest mana noigal (mental disorders). Agathiyar maanidar kirigai nool 
and yugi chinthamani-800 are noteworthy psychiatric literature in Siddha system. They 
classified the clinical variety of mental illness, based on symptomatology. It’s absolutely 
correlates with modern psychiatric illness like depression, schizopernia, mania, convulsive 
disorders, neurotic illness, drug dependence and toxic psychosis etc. 
 VIYAGULA UNMATHAM(DEPRESSION):  
             Viyagula unmatham is a type of unmatham which is a psychiatric disease described in 
the texts of “Sirappu marythuvam” by Dr.R. Thiyagarajan and “Siddha Maruthuvam Pothu” 
by K. N. Kuppusami Muthaliyar and also “Noi Naadal Noi Muthal Naadal Thiraddu - Part - 
2” by Dr. M. Shanmugavelu.)      
UNMATHAM (DEFECTED NORMAL MENTAL STATE): 
Other name: veri noi, pithu noi, paithiya noi ,pitha noi, unmatham. 
          It is a psychic disorder, develops as changed normal mental state due to the vitiation of 
three humours viz vatham, pitham and kapham. Changed mental state, loss of intelligence, 
articulation defect, dancing, singing, continuous working mania, quarrelling and beating. 
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Murkurigal: 
➢ Reduced mental function 
➢ Excessive anger. 
➢ Mood swings. 
➢ Low pitched or high-pitched voice. 
➢ Lethargy. 
➢ Blabbering and whispering always. 
➢ Abnormal behaviour. 
Noi varum vazhi: 
The disease occurs due to destruction physical and mental factors of the body. The 
reasons for this are, 
➢ Increased intake of food, 
➢ Excessive starvation, 
➢ Drug abuse, 
➢ Increased desires,  
➢ Frighten, 
➢ Frequent agitation. 
Hence the disease can occur in association with vadha disease like pakkavatham, valipu 
noi, its also seen in persons those who were undergoing ailments for long time and also in 
postpartum ladies whose health is severely affected. 
The disease can also occur due to wrong practice of yogam during the thuriya avaththai 
state. Since this disease occurs due to deranged azhal kutram(piththam), is called paithiya noi. 
The persons whose mental state is disturbed and who keeps on blabbering whatever he likes 
they are commonly called as paithiyam. 
TYPES OF UNMATHAM: 
Unmatham classified into 6 types, 
• Vatha Unmatham: 
Affected mental state, articulation defect, dancing, singing, quarrelling and 
beating are the general symptoms of vatha unmatham. 
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• Pitha unmatham: 
Frightening others, abnormal body movements, interested in cold items. 
• Kapha unmatham: 
Insomnia, frightening others, sexual indulgence,self-centeredness, 
possessiveness. 
• Mukkuttra unmatham: 
The mixed signs and symptoms of vatham, pitham and kapham unmatham is 
called mukkuttra unmatham. 
• Viyagula unmatham: 
Anxiety and depression due to bereavement, sorrow and grief, paleness, loss of 
wealth and weeping are the symptoms of this disease. 
• Nanju unmatham: 
Toxicity of metals and others, which affects the brain, drug abuse, tiredness of 
extremities, sensory organs, blackish discoloration of the body, general debility, 
weakness of the body and perplexity are the symptoms of these diseases. 
COMMON SYMPTOMS: 
➢ Mental instability, 
➢ Restlessness, 
➢ Loss of control,  
➢ Confined thoughts, 
➢ Speaking loudly,    
➢ Sleeplessness, 
➢ Blabbering, 
➢ Slurred speech, 
➢ Lack of interest, 
➢ Loss of strength. 
AETIOLOGY:  
In the text of agathiyar kirisa nithana nool, 
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In the text book of yugi maa munivar vaiththiya sinhthamani 800, 
Vigara pitham: 
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➢ Sleeplessness, 
➢ Bitter taste in mouth, 
➢ Hatredness, 
➢ Redness of eyes, 
➢ Pallor of body with body pain,  
➢ Vomiting, 
➢ Giddiness, 
➢ Lack of vigilance, 
➢ Dribbling of saliva.  
Unmaatha pitham 
➢ Generalised weakness, 
➢ Increase appetite, 
➢ Heaviness of head, 
➢ Stillness, 
➢ Mute, 
➢ Sleeplessness, 
➢ Dribbling of saliva, 
➢ Discomfort in Chest. 
Uratha pitham 
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➢ Increased anger, 
➢ Quarrelling, 
➢ Flatulence, 
➢ Lack of intelligence, 
➢ Redness of eyes, 
➢ Sleeplessness, 
➢ Weight gaining. 
MUKKUTRA VERUPAADU: 
                    “
 
Due to food and activities of azhal kutram vitiated from its normal level and affects 7 
physical constituents one by one that leads to emaciation of the body with mental abnormalities. 
NAADI NADAI: 
         
 “
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TREATMENT: 
Thiruvalluvar says in “Thirukkural” about physician‟s duty to study the disease, Study 
the cause, seek subsiding ways and do what is proper and effective. 
   In Siddha system of medicine, the main aim of the treatment is to cure Udalpini and 
Manapini. Treatment is not only for perfect healing but also for prevention and rejuvenation. 
In siddha system of medicine line of treatment are as follows, 
➢ Neekam (Treatment)  
➢ Niraivu (Rejuvenation)  
➢ Kappu (Prevention) 
1.Neekam (Treatment):  
• 
• 
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• 
• 
➢ Viresanam: 
Siddha system of medicine is based on three humours and hence the treatment is 
mainly aimed to bring the three humours to equilibrium state and thereby restoring the 
physiological condition of the seven thathus. 
➢ Internal medicine: 
The medicines which are taken internally are called as internal medicines. These are 
classified into 32 types, e.g. surasam, saaru, pittu, vadagam and chooranam, thylam  
➢ External medicine:  
The medicines which are applied externally are called as external medicines. These 
also classified into 32 types, e.g.kattu, patru, otradam, vedhu and thokkanam. 
➢ Anubanam(vehicle): 
➢ Pathiyam (Dietary Regimen):           
 In mild conditions of the disease, salt and tamarind can be taken in little quantities. 
When the condition is severe, tamarind should be avoided and salt must be consumed after 
frying. 
 
2.Niraivu (Rejuvenation): 
 
13 
 Substances used for neutralising the three humours are: 
 
The patients are well motivated. The nature and course of the disease is explained to 
them, Life-style modification advised.  
3.Kappu (Prevention):   
 Ideal measures mentioned in the Siddha classical text Pathartha guna chinthamani for 
healthy living as below, 
The disease occurs due to activities that increase azhal and consuming food that increases 
azhal, so in order to correct the diseases we have to normalize the deranged azhal and there by 
the other factors. 
➢ Ghee based medicine, milk to be administered initially and take purgation and 
therapeutic vomiting may be advised. 
➢ Medicine which improves the strength of the body. 
➢ Yogam is the important kayakalpam to treat psychiatric diseases 
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       YOGAM 
   
Yogam is one of the kayakalpam methods that preserve physical and mental health by 
preventing the approach of wrinkling physical and mental health. The practice of yoga 
integrated the body with the mind and the mind with the soul. Daily practices gradually bring 
about a change of thoughts, conduct, attitude, behaviour and personality. Ones feels a unique 
enthusiasm fearlessness, happiness, dedication, faith, self-confidence, courage, boldness, 
satisfaction, peace and contentment, culminating into physical fitness and mental stability and 
emotional quietness and ultimately a fruitful life. 
Yogam helps to integrate all our five sense organs to react the ecstasy of life following 
a disciplined manner. There are 8 types, 
➢ Iyamam   
➢ Niyamam 
➢ Aadhanam  
➢ Pranayamam 
➢ Prathiyagaram 
➢ Dharanai 
➢ Dhiyanam 
➢ Samadhi 
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 These are called “attanga yogam” or sub conscious meditation, which is given in 
thirumanhthiram. 
IYAMAM: 
Iyamam means “learning disicipline”, it is an internal practice of cleansing or purifying 
the mind.  
NIYAMAM: 
The niyamam means “purity of action”. The niyamas are austerity, contentment, belief 
in god, charity, worship of god, listening to explain to doctrines, scriptures, modesty, having a 
discerning mind, repetition of prayers and sacrifice. 
AASANAM: 
The aasanam means posture or pose, that is, the position of our body with reference to 
space. All the aasanams prove to be a good training to both body and mind. 
PRANAYAMAM: 
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  The perfect and scientific art of controlling one’ s breathing is called pranayamam. 
PIRATHIYAGARAM: 
The prathiyagaram is the method of withdrawal of sense organs from the external 
objects. 
DHARANAI: 
Dharanai is fixing the attention on a single object. 
DHIYAANAM
Dhiyaanam is intense contemplation of the nature of the nature of the object of 
meditation. Meditation on the elements, beginning with the “random” and ending with the 
“inner consciousness”, enable one to gain mastery over the perception. 
SAMAADHI: 
Samaadhi is to merging consciousness with the object of meditation
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Aasanam advised for viyagula unmatham: 
1.Thamarai aasanam(padmasanam): 
 
 
 
Technique: 
❖ Put the right leg on the left thigh, keeping the right heel pressing the lower 
abdomen, 
❖ Put the left leg on the right thigh keeping the left heel pressing the lower 
abdomen. 
Benefits: 
❖ Mental concentration is increased. 
❖ Prevents joint disorders in the old age. 
❖ Increase the digestive function. 
❖ Produces clarity of the mind and briskness. 
 
 
 
 
 
18 
2.Mutrudal aasanam(sarvangasanam): 
 
 
 
Technique: 
❖ Lie down on our back with palms facing upwards adjoining the body and legs put 
together. 
❖ Raise the legs straight upwards and raise the body supporting the hip with hands till 
the chin comes into contact with the chest. 
Benefits: 
❖ Increase the memory power. 
❖ Strengthening the nervous system. 
❖ Its beneficial to persons suffering from hypothyrodisum. 
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3.Kalappai aasanam(halasanam): 
 
 
 
Technique: 
❖ Lie down and pressing the palms downwards, raise the legs up and flexing the hip 
and knees. 
❖ Stretch the legs straight upwardly raise and flex the hip in the direction of the 
head. 
Benefits: 
❖ It strengthens the brain and spinal cord 
❖ It stimulates thyroid gland and regulates its function. 
❖ It strengthens the abdominal organs. 
❖ The asana increases sexual indulgence. 
4.Paambu aasanam(pujangaasanam): 
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Technique: 
❖ Lie face downwards with leg stretched and chin rest on the floor. 
❖ Raise the chest and head slowly and gradually as high as possible above the level 
of umbilicus 
Benefits: 
❖ Relives loss of sleep. 
❖ Increases memory power. 
❖ Relives constipation and increased appetite. 
❖ Its prevents menstural disorders and preventing discharge of semen during sleep. 
5. Munvalaivu aasanam(Patchimottaasanam): 
Technique: 
❖ Sit down with the legs stretched forwards  
❖ Bend forward to rest the face in between the knees and hold the feet with the 
hands of the stretched arm. 
Benefits: 
❖ sexual indulgence 
❖ Increase the appetite 
❖ Strengthens spinal cord and legs. 
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6.Savasanam (shanthi aasanam): 
 
Technique: 
❖ Lie down on the floor with an even surface. 
❖ Palm facing upward and half a foot gap in between the heels, keep the legs in 
relax manner. 
Benefits: 
❖ Relieves physical and mental tiredness. 
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      MODERN ASPECT 
INTRODUCTION 
Depression is a common mental disorder that presents with depressed mood, loss of 
interest or pleasure, feelings of guilt or low self-esteem, disturbed sleep or appetite, low energy, 
and poor concentration. When these problems last for a short period of time, it may be called a 
passing case of “the blues.” But it’s likely to be a depressive disorder when they last for more 
than two weeks and interfere with regular daily activities. 
Depressive disorders, also known as mood disorders, include three main types: major 
depression, persistent depressive disorder, and bipolar disorder. Depressive disorders can affect 
people of any age, including children, teenagers, adults, and older adults. 
               
CAUSES 
Depression varies person to person and occurs due to one or more reasons. Depression 
is most likely due to a combination of genetic, biological, environmental, and psychological 
factors. Occasionally it may appear for no obvious reason. 
Life events 
In many cases, the first time someone becomes depressed, it has been triggered by an 
unwelcome or traumatic event, such as being sacked, divorced, or physically or sexually 
assaulted. 
Loss 
Often events or experiences that triggers depression mainly associated with loss of 
something precious in life. It could be following the actual death of someone close, a major life 
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change (such as moving house or changing jobs), or simply moving from one phase of life into 
another, e.g. as you reach retirement, children leave home, or you come to realize that you may 
never have a family of your own.  
It’s not just the negative experience that causes the depression, but how we deal with 
it. If the feelings provoked are not expressed or explored at the time, they fester and contribute 
towards depression.  
Anger 
In some cases, some people call depression ‘frozen anger’. You may have experienced 
something which left you feeling angry and helpless, and if you were unable to express your 
feelings at the time – perhaps because you were a child, or your feelings were unacceptable to 
others – the anger becomes internalized and is expressed as depression. 
Childhood experiences 
Traumatic event in childhood, or were abused physically or emotionally, or were not 
helped to learn good coping skills as you grew up, this can leave you less able to cope with 
difficulties as an adult. 
Women who have been the victim of physical, emotional, or sexual abuse, either as a 
child or perpetrated by a romantic partner are vulnerable to developing a depressive disorder 
as well. 
Physical conditions 
All medical illnesses and their treatment can act as nonspecific stressors, which may lead 
to mood disorders in predisposed individuals. However, sometimes certain medical conditions 
are believed to play a more direct role in causing the mood disorder (e.g. brain disease, certain 
infections, including HIV, and endocrine disorders).  
The following conditions may cause depression, but are sometimes overlooked because of 
the focus on their physical symptoms:  
• conditions affecting the brain and nervous system   
• hormonal problems, especially thyroid and parathyroid problems; symptoms relating to 
the menstrual cycle or the menopause   
• low blood sugar  
• sleep problems. 
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Different neuropsychiatric illnesses seem to be associated with an overabundance or a 
lack of some of these neurochemicals in certain parts of the brain. For example, a lack of 
dopamine at the base of the brain causes Parkinson's disease. Alzheimer's dementia seems to 
be related to lower acetylcholine levels in the brain. The addictive disorders are under the 
influence of the neurochemical dopamine. That is to say, drugs and alcohol work by releasing 
dopamine in the brain. The dopamine causes euphoria, which is a pleasant sensation. 
Individuals with anxiety, attention deficit hyperactivity disorder (ADHD), substance abuse, 
and developmental disabilities may be more vulnerable to developing depression. 
Side effects of medication 
Certain medications used for a variety of medical conditions are more likely than others 
to cause depression as a side effect, for example, many people become depressed after a heart 
attack, and this may be more likely if they are taking beta blocker medicines as part of their 
treatment. Specifically, some medications that are used to treat high blood pressure, cancer, 
seizures, extreme pain, and to achieve contraception can result in depression. Even some 
psychiatric medications like some sleep aids and medications to treat alcoholism and anxiety 
can contribute to the development of depression. 
Diet 
Poor diet and general lack of fitness can both contribute to depression.  
In addition, anecdotal evidence suggests that occasionally people become very 
depressed in response to some specific foods. Such a reaction is very individual, and people 
are often not aware of the particular food substance or drink that is causing the problem. But if 
you suddenly feel depressed for no apparent reason, it may be worth considering whether you 
have eaten or drunk something new, and whether this might have caused your sudden change 
of mood. If this is the cause, your mood should lift very quickly, so long as you don’t consume 
any more of the particular item.  
Street drugs and alcohol 
Alcohol is a depressant and will tend to make you feel worse overall. Some street drugs 
can also depress, especially if used repeatedly. Repeated use of drugs or alcohol, however, 
desensitizes the dopamine system, which means that the system gets used to the drugs and 
alcohol. Therefore, a person needs more drugs or alcohol to achieve the same high feeling. 
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Thus, the addicted person takes more substance but feels less and less high and increasingly 
depressed. 
Genetics 
Although no specific genes for depression, have been identified, it does seem to run in 
families to some extent, and some of us are more prone to depression than others. This could 
also be because we learn behavior and ways of responding from our ancestors, as well as 
inheriting our genes from them.  
The effect of maternal-fetal stress on depression is currently an exciting area of 
research. It seems that maternal stress during pregnancy can increase the chance that the child 
will be prone to depression as an adult, particularly if there is a genetic vulnerability. It is 
thought that the mother's circulating stress hormones can influence the development of the 
fetus' brain during pregnancy. This altered fetal brain development occurs in ways that 
predispose the child to the risk of depression as an adult. 
Major depression also seems to occur in generation after generation in some families, 
although not as strongly as in bipolar I or II. Indeed, major depression can also occur in people 
who have no family history of depression. 
Chemical changes in the brain:  
 
 
 
(Medial prefrontal affected in depressive mood, which is to planning cognitive 
behaviour, personality expression, decision making and moderating social behaviour) 
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Brain imaging technologies, such as magnetic resonance imaging (MRI), have shown 
that the parts of the brain involved in mood, thinking, sleep, appetite, and behavior of people 
who have depression function differently than those of people without it.  
Because antidepressants work by changing brain chemistry, many people have assumed 
that depression must be caused by changes in brain chemistry that are then ‘corrected’ by the 
drugs. Some psychiatrists may explain you that you have a ‘chemical imbalance’ and need 
medication to correct it. But the evidence for this, apart from the effects of medication, is very 
weak, and if changes to brain chemistry occur, we don’t know whether these are the result of 
the depression or its cause. Although there are physical tests which are occasionally used in 
research on depression, they are not very accurate or consistent, and there are none that are 
done routinely to help make a diagnosis. 
Monoamine pathways, particularly those involving noradrenaline and 5- 
hydroxytryptamine (5- HT), innervate cortical and subcortical brain regions thought to be 
involved in mood regulation. Hypothesis suggests that depressive disorder is due to an 
abnormality in a monoamine neurotransmitter system at one or more sites in the brain. Three 
monoamine transmitters have been implicated— serotonin (5- HT), noradrenaline, and 
dopamine. The latter two neurotransmitters are called catecholamines. Biochemical 
investigations in depressed patients have focused on the monoamine neurotransmitters because 
monoamine pathways appear to play an important role in the actions of effective antidepressant 
drugs. 
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 Finally, the depressive disorders appear to be associated with altered brain serotonin 
and norepinephrine systems. Both of these neurochemicals may be lower in depressed people. 
Please note that depression is "associated with" instead of "caused by" abnormalities of these 
neurochemicals because we really don't know whether low levels of neurochemicals in the 
brain cause depression or whether depression causes low levels of neurochemicals in the brain. 
DEPRESSION SYMPTOMS: 
Depression symptoms include:  
• Feelings of sadness or unhappiness  
• Irritability or frustration, even over small matters  
• Loss of interest or pleasure in normal activities  
• Reduced sex drive  
• Insomnia or excessive sleeping  
• Changes in appetite — depression often causes decreased appetite and weight loss 
• In some people it causes increased cravings for food and weight gain  
• Agitation or restlessness — for example, pacing, hand-wringing or an inability to sit 
still  
• Irritability or angry outbursts  
• Slow thinking, speaking or body movements  
• Indecisiveness, distractibility and decreased concentration  
• Fatigue, tiredness and loss of energy — even small tasks may seem to require a lot of 
effort  
• Feelings of worthlessness or guilt, fixating on past failures or blaming yourself when 
things aren't going right  
• Trouble thinking, concentrating, making decisions and remembering things  
• Frequent thoughts of death, dying or suicide  
• Crying spells for no apparent reason  
• Unexplained physical problems, such as back pain or headaches  
Depression symptoms in children and adolescent: 
Common symptoms of depression can be a little different in children and teens than 
they are in adults.  
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• In younger children, symptoms of depression may include sadness, irritability, 
hopelessness and worry.  
• Symptoms in adolescents may include anxiety, anger and avoidance of social 
interaction.  
• Changes in thinking and sleep are common signs of depression in adolescents and 
adults but are not as common in younger children.  
• In children and teens, depression often occurs along with behavior problems and other 
mental health conditions, such as anxiety or attention-deficit/hyperactivity disorder 
(ADHD).  
• Schoolwork may suffer in children who are depressed.  
Depression symptoms in older adults: 
Depression is not a normal part of growing older, and most seniors feel satisfied with 
their lives. However, depression can and does occur in older adults. Unfortunately, it often goes 
undiagnosed and untreated. Many adults with depression feel reluctant to seek help when 
they're feeling down.  
• In older adults, depression may go undiagnosed because symptoms — for example, 
fatigue, loss of appetite, sleep problems or loss of interest in sex — may seem to be 
caused by other illnesses.  
• Older adults with depression may have less obvious symptoms. They may feel 
dissatisfied with life in general, bored, helpless or worthless. They may always want to 
stay at home, rather than going out to socialize or doing new things.  
• Suicidal thinking or feelings in older adults is a sign of serious depression that should 
never be taken lightly, especially in men. Of all people with depression, older adult men 
are at the highest risk of suicide.  
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SIGNS AND SYMPTOMS OF DEPRESSIVE DISORDER: 
 
1. A depressive disorder is a syndrome (group of symptoms) that reflects a sad and/or 
irritable mood exceeding normal sadness or grief. More specifically, the sadness of depression 
is characterized by a greater intensity and duration and by more severe symptoms and 
functional disabilities than is normal.  
2. Depressive signs and symptoms are characterized not only by negative thoughts, 
moods, and behaviors but also by specific changes in bodily functions (for example, crying 
spells, body aches, low energy or libido, as well as problems with eating, weight, or sleeping). 
The functional changes of clinical depression are often called neurovegetative signs. This 
means that the nervous system changes in the brain cause many physical symptoms that result 
in diminished participation and a decreased or increased activity level.  
3. Certain people with depressive disorder, especially bipolar depression (manic 
depression), seem to have an inherited vulnerability to this condition.  
4. Depressive disorders are a huge public-health problem, due to its affecting millions 
of people. About 10% of adults, up to 8% of teens and 2% of preteen children experience some 
kind of depressive disorder.  
The statistics on the costs due to depression in the United States include huge amounts of direct 
costs, which are for treatment, and indirect costs, such as lost productivity and absenteeism 
from work or school.  
• Adolescents who suffer from depression are at risk for developing and maintaining 
obesity.  
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• In a major medical study, depression caused significant problems in the functioning of 
those affected more often than did arthritis, hypertension, chronic lung disease, and 
diabetes, and in some ways as often as coronary artery disease.  
• Depression can increase the risks for developing coronary artery disease, HIV, asthma, 
and many other medical illnesses. Other complications of depression include its 
tendency to increase the morbidity (illness/negative health effects) and mortality 
(death) from these and many other medical conditions.  
• Depression can coexist with virtually every other mental health illness, aggravating the 
status of those who suffer the combination of both depression and the other mental 
illness.  
• Depression in the elderly tends to be chronic, has a low rate of recovery, and is often 
undertreated. This is of particular concern given that elderly men, particularly elderly 
white men have the highest suicide rate.  
5. Depression is usually first identified in a primary-care setting, not in a mental-health 
practitioner's office. Moreover, it often assumes various disguises, which causes depression to 
be frequently underdiagnosed.  
6. In spite of clear research evidence and clinical guidelines regarding therapy, 
depression is often undertreated. Hopefully, this situation can change for the better.  
7. For full recovery from a mood disorder, regardless of whether there is a precipitating 
factor or it seems to come out of the blue, treatment with medication and/or electroconvulsive 
therapy (ECT) and psychotherapy are necessary.  
TYPES OF DEPRESSION: 
Depressive disorders are mood disorders that come in different forms, just as do other 
illnesses, such as heart disease and diabetes. Three of the most common types of depressive 
disorders are discussed below. However, remember that within each of these types, there are 
variations in the number, timing, severity, and persistence of symptoms. There are also 
differences in how individuals experience depression based on age.  
Major depression: 
Major depression is characterized by a combination of symptoms that last for at least 
two weeks in a row, including sad and/or irritable mood (see symptom list), that interfere with 
the ability to work, sleep, eat, and enjoy once pleasurable activities. Difficulties in sleeping or 
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eating can take the form of excessive or insufficient of either behavior. Disabling episodes of 
depression can occur once, twice, or several times in a lifetime.  
Dysthymia: 
 Dysthymia is a less severe but usually more long-lasting type of depression compared 
to major depression. It involves long-term (chronic) symptoms that do not disable but yet 
prevent the affected person from functioning at "full steam" or from feeling good. Sometimes, 
people with dysthymia also experience episodes of major depression. This combination of the 
two types of depression is referred to as double-depression.  
Bipolar disorder (manic depression):  
Another type of depression is bipolar disorder, which encompasses a group of mood 
disorders that were formerly called manic-depressive illness or manic depression. These 
conditions show a particular pattern of inheritance. Not nearly as common as the other types 
of depressive disorders, bipolar disorders involve cycles of mood that include at least one 
episode of mania or hypomania and may include episodes of depression as well. Bipolar 
disorders are often chronic and recurring. Sometimes, the mood switches are dramatic and 
rapid, but most often they are gradual. When in the depressed cycle, the person can experience 
any or all of the symptoms of a depressive disorder. When in the manic cycle, any or all of the 
symptoms listed later in this article under mania may be experienced. Mania often affects 
thinking, judgment, and social behavior in ways that cause serious problems and 
embarrassment. For example, indiscriminate or otherwise unsafe sexual practices or unwise 
business or financial decisions may be made when an individual is in a manic phase. A 
significant variant of the bipolar disorders is designated as bipolar II disorder. (The usual form 
of bipolar disorder is referred to as bipolar I disorder.) Bipolar II disorder is a syndrome in 
which the affected person has repeated depressive episodes punctuated by what is called 
hypomania (mini-highs). These euphoric states in bipolar II do not fully meet the criteria for 
the complete manic episodes that occur in bipolar I.  
Postpartum depression: 
Postpartum depression (PPD) is a condition that describes a range of physical and 
emotional changes that many mothers can have after having a baby. PPD can be treated with 
medication and counseling. Talk with your health-care practitioner right away if you think you 
have PPD. There are three types of PPD women can have after giving birth 
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1. The so-called "baby blues" happen in many women in the days right after childbirth. 
A new mother can have sudden mood swings, such as feeling very happy and then feeling very 
sad or angry. She may cry for no reason and can feel impatient, irritable, restless, anxious, 
lonely, and sad. The baby blues may last only a few hours or as long as one to two weeks after 
delivery. The baby blues do not always require treatment from a health-care provider. Often, 
joining a support group of new moms or talking with other moms helps.  
  2. Postpartum depression (PPD) can happen a few days or even months after childbirth. 
PPD can happen after the birth of any child, not just the first child. A woman can have feelings 
similar to the baby blues -- sadness, despair, anxiety, irritability -- but she feels them much 
more strongly than she would with the baby blues. PPD often keeps a woman from doing the 
things she needs to do every day. When a woman's ability to function is affected, this is a sure 
sign that she needs to see her healthcare provider right away. If a woman does not get treatment 
for PPD, symptoms can get worse and last for as long as one year. While PPD is a serious 
condition, it can be treated with medication and counseling.  
 3. Postpartum psychosis is a very serious mental illness that can affect new mothers. 
This illness can happen quickly, often within the first three months after childbirth. Women 
can experience psychotic depression, in that the depression causes them to lose touch with 
reality, have auditory hallucinations (hearing things that aren't actually happening, like a person 
talking), and delusions (seeing things differently from what they are in reality). Visual 
hallucinations (seeing things that aren't there) are less common. Other symptoms include 
insomnia (not being able to sleep), feeling agitated (unsettled) and angry, strange feelings and 
behaviors, as well as having suicidal or homicidal thoughts. Women who have postpartum 
psychosis need treatment right away and almost always need medication. Sometimes women 
are put into the hospital because they are at risk for hurting themselves or someone else, 
including their baby.  
DEPRESSION DIAGNOSIS: 
People who wonder if they should talk to their health professional about whether or not 
they have depression may consider taking a depression self-test, which asks questions about 
depressive symptoms. In thinking about when to seek medical advice about depression, the 
sufferer can benefit from considering if the sadness lasts more than two weeks or so or if the 
way they are feeling significantly interferes with their ability to function at home, school, or 
work and in their relationships with others. The first step to obtaining appropriate treatment is 
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accurate diagnosis, which requires a complete physical and psychological evaluation to 
determine whether the person may have a depressive illness, and if so, what type. As previously 
mentioned, certain medications, as well as some medical conditions, can cause symptoms of 
depression. Therefore, the examining physician should rule out (exclude) these possibilities 
through an interview, physical examination, and laboratory tests. Many primary-care doctors 
use screening tools, symptoms tests, for depression, which are usually questionnaires that help 
identify people who have symptoms of depression and may need to receive a full mental-health 
evaluation.  
The doctor usually asks about alcohol and drug use and whether the patient has had 
thoughts about death or suicide. Further, the history often includes questions about whether 
other family members have had a depressive illness, and if treated, what treatments they 
received and which were effective.  
A diagnostic evaluation also includes a mental status examination to determine if the 
patient's speech, thought pattern, or memory has been affected, as often happens in the case of 
a depressive or manic-depressive illness. As of today, there is no laboratory test, blood test, or 
Xray that can diagnose a mental disorder. Even the powerful CT, MRI, SPECT, and PET scans, 
which can help diagnose other neurological disorders such as stroke or brain tumors, cannot 
detect the subtle and complex brain changes in psychiatric illness. However, these techniques 
are currently useful in research on mental health and perhaps in the future they will be useful 
for diagnosis as well.  
RISK FACTORS  
Risk factors of depression 
 
Lack of social support Social support serves as a protective factor 
against depression. People who are isolated 
and have few friends or family members to 
turn to in times of stress are more likely to 
develop depression. 
Recent stressful life experience When people are going through stressful 
experiences that overwhelm their coping 
skills, depression often results. 
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Previous history of Depression If you’ve had an episode of major 
depression before, you are at increased risk 
of having another episode. The probability 
of having a recurrence increases with each 
major depressive episode. 
Family history of Depression If depression runs in your family, your risk 
for depression is higher. Your risk is 
particularly high if one of your close 
relatives, such as parent or sibling, had 
depression 
Lower socioeconomic status Research has shown that low socioeconomic 
status is associated with increased rates of 
depression. People with lower levels of 
income, education, and occupational status 
face many obstacles and stressors that likely 
contribute to this risk. 
Underlying emotional or personality 
disorder 
People with pervasive emotional difficulties 
or personality disorders are vulnerable to 
depression. 
Chronic medical condition Ongoing medical problems or chronic pain 
can lead to depression 
Female sex 
 
Women are twice as likely to experience 
depression as men. 
Advanced age People over the age of 65 are more 
vulnerable to depression. 
 
COMPLICATIONS: 
People who are depressed are more likely to use alcohol or illegal substances.  
Complications of depression also include:  
• Increased risk of physical health problems  
• Suicide  
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 Thoughts of Death or Suicide: 
People suffering from depression often show distorted thinking. Everything looks bleak 
to them, and they hold extremely negative views about themselves, their situation, and the 
future. Trapped in their pessimism, they brood/obsess over their problems and blow them out 
of proportion. Feeling hopeless and helpless, they may even start to see suicide as their only 
way out. 
Suicidal thoughts are a symptom of severe depression and must always be taken 
seriously. If someone you know is threatening suicide or talking of wanting to hurt him/herself, 
seek professional help right away. 
PROGNOSTIC FACTORS: 
The best predictor of the future course is the history of previous episodes. Not surprisingly, 
the risk of recurrence is much higher in individuals with a history of several previous episodes. 
Other factors that predict a higher risk of future episodes include the following: 
 
• incomplete symptomatic remission 
• early age of onset 
• poor social support 
• poor physical health 
•  substance abuse 
• comorbid personality disorder 
 
The various risk factors, particularly previous pattern of recurrence and the extent of 
current remission, have important implications for the use of longer- term maintenance 
treatments. In many patients, depressive disorders are best conceptualized as chronic relapsing 
conditions that require an integrated longterm treatment approach. 
DIFFERENTIAL DIAGNOSIS OF DEPRESSIVE DISORDERS: 
Depressive disorders have to be distinguished from the following: 
• normal sadness 
• adjustment disorder 
• anxiety disorders 
• schizophrenia 
• organic brain syndromes. 
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PREVENTION: 
Do not drink alcohol or use illegal drugs. These substances can make depression worse 
and might lead to thoughts of suicide.  
Take your medication exactly as your doctor instructed. Ask your doctor about the 
possible side effects and what you should do if you have any. Learn to recognize the early signs 
that your depression is getting worse. The following tips might help you feel better:  
• Do exercise  
• Maintain good sleep habits  
• Seek out activities that bring you pleasure  
• Volunteer or get involved in group activities  
• Talk to someone you trust about how you are feeling 
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DRUG REVIEW 
INTERNAL DRUG:  
THIRUTHARATCHATHA CHOORANAM: 
Ingredients: 
➢ Mundhiri(Anacardium occidentale)- 1 Palam 
➢ Pericham(Phonex dactilifera))- 1 Palam 
➢ Adhimadhuram(Glycyrrhiza glabra))- 1 Palam 
➢ Elam(Electaria cardamoum))- 1 Palam 
➢ Thippili(Piper longum))- 1 Palam 
➢ Nerpori(Oryza sativa))- 1 Palam 
➢ Krambu(Syzigium aromaticum))- 1 Palam 
➢ Ilavanga Pathiri(Cinnamomum tammla))- 1 Palam 
➢ Kodiveli(Plumbago indica))- 1 Palam 
➢ Koogai Neeru(Maran arundingcea))- 1 Palam 
➢ Muthakasu(Cyprus rotundus))- 1 Palam 
➢ Mutkai Velai(Gynandropis gynandra))- 1 Palam 
➢ Milagu(Piper nigram))- 1 Palam) 
➢ Kothumalli(Coriandrum sativam) )- 1 Palam 
Method of preparation: 
 Each drug in these ingredients are dried and made it into fine powder and add equal 
quantity of sugar. 
Internal medicine : THIRTHARAKCHATHA CHOORANAM 
Dosage  : 2 gm, twice a day  
Vehicle           : Ghee  
Duration of treatment:  45 days 
EXTERNAL MEDICINE 
ARUGANVER THYLAM
 
Ingredients 
➢ Aruganver(Cynodan dactylon)- 8 pangu 
➢ Karpogarisi(Psoraiea corylifolia) -1 kalanju 
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➢ Vetti ver(Vettiveria zizanioides)-1 kalanju 
➢ Kostam(Costus specious)-1 kalanju 
➢ Nalennai(Sesamum indicum)-1 kalanju 
Method of preparation 
 Arugan ver kudineer is prepare into 8:1 ratio. The extract is mix with gingely oil 
other ingredients are finely powder and added to it. The mixture is boiled and filtered. 
PROPERTIES OF TRIAL DRUGS 
1.THIRUTHARAKCHATHA CHOORANAM (INTERNAL MEDICINE) 
1.Mundhiri 
Botanical Name :  Anacardium occidentale 
English Name : Cashew nut tree 
Family       :  Anacardaceae 
Part used   :  Nut 
Organoleptic Characters 
Taste     :  Inippu  
Potency    :  Thadpam  
Division    :  Inippu  
General Property:  
Chemical Constituents: 
➢ Cardol 
➢ Anacardic acid 
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Action 
➢ Tonic 
➢ Aphrodisiac 
➢ Diuretic 
Medical uses 
Latex substance from its bark used to heal the leprosy ulcer, an oil taken from the 
epidermis of the fruit heals foot fissure.    
2.Pericham 
Botanical Name  :  Phoenix dactilifera 
English Name  : Date palm 
Family     : Arecaceae 
Part used  : Fruit, Gum 
Organoleptic Characters 
Taste         :   Inippu 
Potency     :  Veppam 
Division    :  Kaarpu 
General Property 
Chemical Constituents 
The predominant mineral was Potassium and rich in sugar. They contained high 
concentration of aspartic acid, proline, alanine, glycine, valine and leucine. The sugars were 
glucose and fructose. 
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Action 
➢ Tonic 
➢ Stomachic 
➢ Refrigerant 
➢ Aphrodisiac 
Medicinal uses 
Its fruit cures dysentery, leucorrhoea, fever. The Gum when consumed along with 
water cures urinary tract infection and diarrhoea.                       
3.Adhimadhuram 
Botanical Name  :  Glycyrrhiza glabra 
English Name  :  Jequitity 
Family   :  Fabaceae  
Part Used   :  Root 
Organoleptic Characters 
Taste                           :           Inipu  
Potency    :  Seetham 
Division    :  Inipu 
General Property: 
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Chemical Constituets 
Triterpenoid saponin-glycyrrhizin (2-20%), a mixture of potassium and calcium salts 
of glycyrrhizic (glycyrrhetinic) acid. Triterpene sterols, teiterpenoid saponins, glycyrrhetol, 
isoglabridin A, B, herniarin. 
Action 
➢ Anti ulcer  
➢ Anti hepatotoxic 
➢ Estrogenic 
➢ Anxiolytic 
➢ Cytochrome p450A4  inhibitory. 
Medicinal uses 
  It cures cough bronchial asthma, reduces the effects of diseases like jaundice, vitiligo, 
mental disorder and eye diseases.  
4.Elam 
Botanical Name  :  Elettaria cardamoum 
English Name  : cardamom seeds 
 Family   :  Zingieraceae 
Part used   :  Seed 
Organoleptic Characters  
Taste     :  Kaarpu 
Potency    :   Veppam 
Division    :  Kaarpu 
General Property  
 
42 
Chemical Constituents 
It consists some terpenes like Cineol and Limonene 
Action: 
➢ Stimulant 
➢ Carminative 
➢ Stomachic 
Medicinal uses: 
  It is used to treat wide range of Gastrointestinal disorders such as gastritis, peptic ulcers 
etc. 
5.Thippili 
Botanical Name  :  Piper longum 
English Name  :  Long piper 
 Family   :  Piperaceae 
Organoleptic Characters  
Taste     :  Inippu 
Potency    :  Thatpam 
Division    :  Inipu 
General Property   
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Chemical Constituent 
                       Piperine (4-5%) and volatitle oil (1%) and piperlonguminine, piplartine, 
piperundecalidine, seasamin, resin, dihydrostigmasterol. 
Action: 
➢ Hepato protective 
➢ Sedative 
➢ Analgesic 
➢ Cholagogue 
Medicinal uses 
It roots cures cough, bronchial asthma, peptic ulcer. The extract of Thippili with milk 
administer for muppini. It is also used as an Antidote. 
6.Nerpori 
Botanical Name  :  Oryza sativa 
English Name  :  paddy 
 Family   :  Poaceae 
Organoleptic Characters 
Taste     :  Inipu 
Potency    :  Thatpam 
Division    :   Inipu 
General Property   
Chemical Constituents 
               Whole grain rice contains significant amounts of vitamin B1, B2, B6, E and Niacin.  
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Action 
➢ Nutrient 
➢ Demulcent 
➢ Refrigerant 
Medicinal uses 
It has anti-inflammatory action when applied externally. Rice powder with turmeric 
powder reduces swelling in condition of muscle sprain or any injury. 
7.Kirambu 
Botanical Name  :  Syzigium aromaticum 
English Name  :  Cloves 
 Family   :  Myrtaceae 
Part used   :  Dried flower bud 
Organoleptic characters  
Taste     :  Karam  
Potency    :  Veppam 
Division    :   Kaarpu 
General Property   
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Chemical Constituents 
Volatile oil (15-20%) containing chiefly a phenol eugenol (55-85%) and beta 
caryophyllene (-10-20%) and eugenol acetate and derivatives of B-caryophyllene, 
acetophenone, benzyl salicylate, propylbenzoate. 
Action 
➢ Antispasmodic 
➢ Carminative 
➢ Stomachic 
➢ Antioxidative 
➢ Anti-thrombotic 
Medicinal uses: 
              Its oil cures Gingivitis, sensitive tooth and tooth carries and was applied by dipped 
cotton. Its powder with water when applied on fore head and nasal ridge reduces sinus head 
ache.   
8.Ilavanga Pathiri 
Botanical Name  :  Cinnamomum tammla 
English Name  :  cloves  
 Family   :  Lauraceae 
Organoleptic Characters   
Taste     :  Kaarpu,viruviruppu 
Potency    :  Veppam 
Division    :  Kaarpu 
 General Property  
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Action 
➢ Antispasmodic 
➢ Carminative 
➢ Stomachic 
Medicinal uses 
              Its leaf cures asthma, cough, excessive thirst, vomiting and fever.  
9.Kodiveli 
Botanical Name  :  Plumbago indica 
English Name  :  Ceylon lead-wort 
 Family   :  Plumbaginaceae 
Part Used   :  Root  
Organoleptic Characters   
Taste     :  Kaarpu 
Potency    :   Veppam 
Division    :  Kaarpu 
General Property   
Chemical Constituents 
                  Plumbagin, Tannin, Steroids, glucoside, triterpenes 
Action 
➢ Stimulant 
➢ Rubefacient 
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Medicinal uses 
  Roots are used in the treatment of paralytic affections, ulcers, leprosy, enlarged spleen, 
piles, skin diseases and influenza. The plumbagin shows antimicrobial activity. Plumbagin is 
an important naphthoquinone which has anticancer activity, antibacterial, antifungal, 
antimutagenic, anti-inflammatory and insecticidal activities.  
10.Koogai Neeru 
Botanical Name  :  Maran arundinacea 
English Name  :  East Indian arrow root 
Organoleptic Characters  
Taste     :  Inippu 
Potency    :  Thatpam 
Division    :  Inippu 
General Property   
Action 
➢ Refrigerant 
➢ Demulcent 
➢ Nutrient 
Medicinal uses 
 Powdered root reduces stomach pain and diarrhoea in people with Irritable Bowel 
Syndrome. 
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11.Muthakasu 
Botanical Name  :  Cyprus rotundus 
English Name  :  nut grass 
 Family    :  Cyperaceae  
Organoleptic Characters 
Taste     :  Inipu  
Potency    :  Thatpam 
Division    :  Inipu 
General Property   
Chemical Constituents 
Pinene, Cineole, Sesquiterpenes, Glycerol, Linolenic acid, Linoleic acid, Oleic acid. 
Action 
➢ Astringent 
➢ Tonic  
➢ Stimulant 
➢ Demulcent 
➢ Tonic 
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Medicinal uses 
 Its root used to cure Hypertension, Tuberculosis. Its root extract added in 
Nalangumavu preparation.                  
12.Nal Velai 
Botanical Name  :  Gynandropis gynandra 
English Name  :  dog mustard 
 Family   :  Caparaceae 
Part Used   :  Leaf, Flower, Seed, Root 
Organoleptic Characters  
Taste     :  Kaarpu 
Potency    :  Veppam 
Division    :  Kaarppu 
General Property   
 Chemical Constituents  
Beta carotene, Folic acid, ascorbic acid, calcium, Vit E and Iron.    
Action: 
➢ Antispasmodic 
➢ Carminative 
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Medicinal uses 
The leaves have anti oxidative properties and used in inflammatory diseases. Juice of 
the root is used to relieve scorpion stings.  
13.Milagu 
Botanical Name  :  Piper nigram 
English Name  :  black pepper 
 Family   :  Piperaceae 
Parts Used   :  Seed  
Organoleptic Characters 
Taste     :  kaippu,kaarppu 
Potency    :  veppam 
Division    :  kaarppu 
General Property   
Chemical Constituent 
 The drug contains volatile oil (1-2.5%). Alkaloids/amides (5-9%), and a resin. 
➢ Major: A pungent alkaloid, piperine (2-5%). 
➢ Minor: a number of alkaloids/amides ex: piperine, piperettine, piperanine, 
piperamides, pipericide ,gunineensine ,saramenttine,Propenylphenols viz.,eugenol 
,myristicine ,safrol e;mono and sequiterpenes. 
Action  
➢ Anti-convulsant properties 
➢ CNS depressant 
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➢ Analgesic 
➢ Anti-oxidant 
➢ Hepatoprotective  
Medicinal uses 
Fruits used in indigestion, asthma, fever, cough, arthritis and haemorrhoids. 
14.Kothumalli 
Botanical Name  :  Coriandrum sativam  
English Name  :  coriander seeds 
 Family   :  Apiaceae  
Parts Used   :  Leaf , Seed 
Organoleptic Characters  
Taste                           :   kaarpu  
Potency    :  setha veppam 
Division    :  kaarpu 
General Property   
Chemical Constituents 
Essential oil (-1%), the major component of which is S-(+)-linalool (60-70%), 
monoterpene hydrocarbons, thiazole,coriandrones A-E,flavonoids,phthalides,phenolic acids 
and sterols. 
Action 
➢ Hypolipidemic 
➢ Preventive effect on lead deposition 
➢ Insulin releasing 
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➢ Spasmolytic 
➢ Stomatic 
➢ Carminative 
Medicinal uses 
              Its dried seed extract strengthens the heart, chewing its plain fruit reduces bad odour 
from mouth. It also used for indigestion, dehydration, vomiting. 
EXTERNAL MEDICINE 
ARUGANVER THYLM 
1.Aruganver 
Botanical Name  :  Cynodan dactylon 
English Name  :  Barmuda Grass 
Family   :  Poaceae 
Parts Used   :  Grass , Root 
Organoleptic Characters  
Taste     :  Inippu 
Potency    :   Thatpam 
Division    :  Inippu 
General Property   
Chemical constituent 
Palmitic acid, arundoin, beta carotene, ergonovine 
Action 
➢ Emolient 
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➢ Astringent 
➢ Duretic   
➢ Styptic 
Medicinal uses 
Extract cures all bleeding disorders, scabies and tinea. It acts as an antidote for rat 
bite. 
2.Karpogarisi 
Botanical Name  :  Psoraiea corylifolia 
English Name  :  Babchi Seeds 
Family   :  Faaceae  
Parts Used   :  Seed 
Organoleptic Characters 
Taste     :   Kaippu 
Potency    : Veppam 
Division    :  Kaarpu 
General Property   
Chemical constituent 
Psoralen, flavanoid, cowmarin, meroterpenes. 
Action 
➢ Laxative 
➢ Stimulant 
Medicinal uses 
Acts as an antidote for snake bite, it cures ulcers, tinea and other skin disorders. 
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3.Vetti ver 
Botanical Name  :  Vettiveria zizanioides 
English Name  :  Cuscus root 
Family   :  Poaceae 
Parts used   :  Root 
Organoleptic Characters  
Taste     :  Inippu  
Potency    :   Thatpam 
Division    :  Inippu 
 General Property 
Chemical constituent 
Vetivene, khusimene, khusimone, furfura, benzoic acid    
Action 
➢ Tonic 
➢ Stimulant 
➢ Anti-spasmodic 
➢ Emmenagogue 
Medicinal uses 
It cures hypertension, excessive thirst, fever and jaundice. 
4.Kostam 
Botanical Name  :  Costus specious 
English Name :  Costus Root  
 Family   :  Zingiberaceae 
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Organoleptic Characters  
Taste     :  Kaippu , viruviruppu 
Potency    :  Veppam 
Division    :   Kaarpu 
General Property  
Chemical constituent 
Succinic acid, beta sitosterol, tetra cosanoic acid, daucosterin.    
Action  
➢ Stomachic 
➢ Expectorant 
➢ Tonic 
➢ Stimulant 
Medicinal uses: 
It is used in case of fever and haemorrhoids. It also acts as an antidote for snake and 
rat bite. 
5.Nalennai 
Botanical Name  :  Sesamum indicum 
English Name  :  Gingelly oil plant 
Parts Used   :  Leaf , Flower , Raw Seed 
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Family   :  Pedaliaceae  
Organoleptic Characters  
Taste     :  Inippu  
Potency    :  Veppam 
Division    :  Inippu 
General Property 
Chemical constituent 
Vitamin E, Sesamin, Sesamolin, Phytosterol. 
Action 
➢ Laxative 
➢ Nutrient  
➢ Emolient 
Medicinal uses: 
It cures ulcers and other skin disorder, eye and ear disorder. 
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           MATERIALS AND METHODS 
STANDARD OPERATING PROCEDURE 
Source of raw drugs 
 The required raw drugs for the trial medicine will be purchased from a well reputed 
country raw drug shop and drugs were authenticated by the competent authority Medicinal 
Botany and Gunapadam dept. After that the raw drugs will be purified as per siddha literatures 
then the trial drugs prepared in Gunapadam laboratory of National Institute of Siddha. 
BOTANICAL AUTHENTICATION CERTIFICATE NO: NISMB3382018. 
INTERNAL DRUG: THIRUTHARATCHATHA CHOORANAM 
 Ingredients 
➢ Mundhiri(Anacardium occidentale)- 1 Palam 
➢ Pericham(Phonex dactilifera) - 1 Palam 
➢ Adhimadhuram(Glycyrrhiza glabra) - 1 Palam 
➢ Elam(Electaria cardamoum) - 1 Palam 
➢ Thippili(Piper longum) - 1 Palam 
➢ Nerpori(Oryza sativa) )- 1 Palam 
➢ Krambu(Syzigium aromaticum) - 1 Palam 
➢ Ilavanga Pathiri(Cinnamomum tammla) - 1 Palam 
➢ Kodiveli(Plumbago indica) )- 1 Palam 
➢ Koogai Neeru(Maran arundingcea) - 1 Palam 
➢ Muthakasu(Cyprus rotundus) - 1 Palam 
➢ Mutkai Velai(Gynandropis gynandra) )- 1 Palam 
➢ Milagu(Piper nigram) - 1 Palam 
➢ Kothumalli(Coriandrum sativam) - 1 Palam 
METHOD OF PURIFICATION OF RAW DRUGS: 
Purification of Munthiri 
Dust particles are removed and the cashews are roasted. 
                             [Marunthu Sei iyalum kalayum: 286] 
Purification of Ellam 
 Dust particles are removed and It is roasted. 
                 [Ref: Sikicha Rathina Deepam Ennum Vaithiya Nool: 28] 
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Purification of Muthakaasu 
Dust particles are removed and It is roasted 
                  [Ref: Marunthu Sei iyalum kalayum] 
Purification of Milagu 
Soak in the buttermilk for three hours then dried and powdered.  
               [Ref: Sikicha Rathina Deepam Ennum Vaithiya Nool page 28]                        
Purification of Thippili 
 Soak in juice of Lime for a period of time   then allowed   it to dry.   
                              [Ref: Sarakugalin sutheemuraigal page 7] 
Purification of Athimathuram 
 Removed the outer cover, cut into small pieces and dried it in shadow.                                     
              [Ref: Sighitcha Rathan Deepam Ennum Vaithiya Nool, Page: 29] 
Purification of Lavangapathiri 
 Removed the flowerlets and dried in the shadow.  
              [Ref: Sighitcha Rathan Deepam Ennum Vaithiya Nool, Page: 29] 
Purification of Kothamalli 
             Removed the dust particles and dried it in shadow. 
                             [Ref : Sarakugalin suthee muraigal page 7] 
Purification of Koogaineer 
  Dissolved and wash it in water for 7 times and dried it in shadow.                     
                            [Ref: Sikicha Rathina Deepam Ennum Vaithiya Nool, page 35]    
Purification of Kirambu 
 Dust particles removed and its dried it in shadow. 
                             [Ref: Sarakugalin  suthee  muraigal  page : 6]    
Purification of Kodivelli                   
Kodiveli ver (root of Plumbago indigo) Removed the inner nerve of the root and 
powder the outer part of root.Took a pot with milk and its mouth was covered with white 
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cloth then the powder over it and closed it with another vessel.It was  heated it for 3 hours 
then dried and grinded.                             
 [Ref:Sigicharathinatheepam :29]      
METHOD OF PREPARATION 
      All the above-mentioned ingredients are taken in equal amount and dried, then made into 
fine powdered and add equal quantity of sugar. The powder is purified. Then the medicine 
stored in an air tight container. 
Dosage :          2 gram twice a day with ghee 
Duration :     48 days   
EXTERNAL MEDICINE: ARUGANVER THYLAM 
Ingredients 
➢ Aruganver (Cynodan dactylon)- 8 pangu 
➢ Karpogarisi (Psorlea corylifolia) -1 kalanju 
➢ Vetti ver (Vettiveria zizanioides) -1 kalanju 
➢ Kostam (Costus specious) -1 kalanju 
➢ Nalennai (Sesamum indicum) -1 kalanju 
METHOD OF PREPARATION 
             The purified Arugan ver (350 gms) mixed with 10.7 litre of  water and heated upto 
1/8th  ratio of water and take it as decoction. The extract is mixed with gingely oil and are 
finely powdered and added to it. The mixture is boiled till it attained the suitable consistency 
and filtered it. 
Dosage: QS 
Drug storage:  
             The trial drug Thirutharatchatha chooranam is stored in clean and dry container 
and Aruganver Thylam is stored in clean and dry narrow mouthed bottles. 
DISPENSING: 
• The Powder is given in packet (28 gram for one week) 
• Oil is given in pet bottles (Q.S for oil bath).   
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       BIO CHEMICAL EVALUATION  
Experimental procedure 
 5 g of THIRUTHARAKCHATHA CHOORANAM was taken in a 250 ml of clean beaker 
and 50ml of distilled water was added to it. Then it was boiled well for about 10 min. Then it 
is allowed to cool and filtered in a 100 ml volumetric flask and made up to 100 ml with distilled 
water. This preparation is used for the qualitative analysis of acidic/ basic radicals and 
biochemical constituents in it.  
Preparation of extract 
5gm of THIRUTHARAKCHATHA CHOORANAM was weighed accurately and 
placed in a 250ml clean beaker and 50ml of distilled water was added with it. Then it was 
boiled well for about 10 minutes. Then it was allowed to cool and filtered in a 100ml volumetric 
flask and made up to 100ml with distilled water. The bio-chemical analysis of 
THIRUTHARAKCHATHA CHOORANAM was done at Biochemistry lab, National Institute of 
siddha, Chennai-47.  
Preliminary test for Copper, Sodium, Silicate and Carbonate 
➢ Test for Silicate: a. A little (500mg) of the sample is shaken well with distilled water. 
b. A little (500mg) of the sample is shaken well with con. HCl/Con. H2So4. 
➢ Action of Heat: A small amount (500mg) of the sample is taken in a dry test tube and 
heated gently at first and then strong. 
➢ Action of Heat: A small amount (500mg) of the sample is taken in a dry test tube and 
heated gently at first and then strong. 
➢ Flame Test: A small amount (500mg) of the sample is made into a paste with con. HCl 
in a watch glass and introduced into non-luminous part of the Bunsen flame. 
➢ Ash Test: A filter paper is soaked into a mixture of sample and dil. cobalt nitrate 
solution and introduced into the Bunsen flame and ignited. 
Test for Acid Radicals  
➢ Test for Sulphate: 2ml of the above prepared extract was taken in a test tube and 2ml 
of 4% dil. ammonium oxalate solution was added. 
➢ Test for Chloride: 2ml of the above prepared extracts was added with 2ml of dil-HNO3 
until the effervescence ceases off. Then 2 ml of silver nitrate solution was added. 
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➢ Test for Phosphate: 2ml of the extract was treated with 2ml of con. HNo3 and 2ml of 
dil. ammonium molybdate solution. 
➢ Test for Carbonate: 2ml of the extract was treated with 2ml dil. magnesium sulphate 
solution 
➢ Test for Nitrate:1gm of the substance was heated with copper turning and concentrated 
H2SO4 and viewed the test tube vertically down. 
➢ Test for Sulphide: 1gm of the substance was treated with 2ml of con. HCL 
➢ Test for Fluoride & Oxalate: 2ml of extract was added with 2ml of dil. Acetic acid 
and 2ml dil. calcium chloride solution and heated. 
➢ Test for Nitrite: 3drops of the extract was placed on a filter paper, on that-2 drops of 
dil. acetic acid and 2 drops of dil. Benzidine solution were placed. 
Test for Basic Radicals 
➢ Test for Lead: 2ml of the extract was added with 2ml of dil. potassium iodine solution.  
➢ Test for Copper: One pinch (50mg) of substance was made into paste with con. HCl 
in a watch glass and introduced into the non-luminous part of the flame. 
➢ Test for Aluminium: In the 2ml of extract dil. sodium hydroxide was added in 5 drops 
to excess.  
➢ Test for Iron: a. To the 2ml of extract add 2ml of dil. ammonium solution  
➢ b. To the 2ml of extract 2ml thiocyanate solution and 2ml of con HNo3 is added  
➢ Test for Zinc: In 2ml of the extract dil. sodium hydroxide solution was added in 5 drops 
to excess and dil. ammonium chloride was added.   
➢ Test for Calcium: 2ml of the extract was added with 2ml of 4% dil. ammonium oxalate 
solution   
➢ Test for Magnesium: In 2ml of extract dil. sodium hydroxide solution was added in 
drops toexcess.  
➢ Test for Ammonium: In 2ml of extract 1 ml of Nessler's reagent and excess of dil. 
sodium hydroxide solution were added.  
➢ Test for Potassium: A pinch (25mg) of substance was treated with 2ml of dil. sodium 
nitrite solution and then treated with 2ml of dil. cobalt nitrate in 30% dil. glacial acetic 
acid. 
➢ Test for Sodium: 2 pinches (50mg) of the substance was made into paste by using HCl 
and introduced into the blue flame of Bunsen burner.  
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➢ Test for Mercury: 2ml of the extract was treated with 2ml of dil. sodium hydroxide 
solution.  
➢ Test for Arsenic: 2ml of the extract was treated with 2ml of dil. sodium hydroxide 
solution.  
Other constituents: 
➢ Test for Starch: 2ml of extract was treated with weak dil. iodine solution   
➢ Test for Reducing Sugar: 5ml of Benedict's qualitative solution was taken in a test 
tube and allowed to boil for 2 minutes and added 8 to 10 drops of the extract and again 
boil it for 2 minutes.   
➢ Test for The Alkaloids: a) 2ml of the extract is treated with 2ml of dil. potassium 
iodide solution.    b) 2ml of the extract is treated with 2ml of dil. picric acid.  
➢ Test for Tannic Acid: 2ml of extract was treated with 2ml of dil. ferric chloride 
solution  
➢ Test for Unsaturated Compound: In the 2ml of extract 2ml of dil. Potassium 
permanganate solution was added.   
➢ Test for Amino Acid: 2 drops of the extract were placed on a filter paper and dried 
well, and then 20ml of Burette reagent was added in it.   
CLINICAL STUDY  
Clinical trail Approval Registration 
The clinical trail was approved by the Institutional Ethical Committee (IEC) of 
National Institute of Siddha, Chennai 47, [ NIS/IEC/2016/11-12/14.10.2016] and further 
registered Clinical Trail Registry of India [REG. NO. CTRI/2018/04/013421]. 
Study type :  An open clinical trial  
Study place :  OPD of Ayothidoss Pandithar Hospital, 
National Institute of Siddha  
        Tambaram sanatorium, Chennai-47  
Study period :  2015-2018  
Sample size :   30 Patients  
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SUBJECT SELECTION:          
Patients reporting with symptoms of inclusion criteria will be subjected to screening 
test and documentation. 
INCLUSION CRITERIA 
➢ Age: between 20 years and 55 years 
➢ Sex: Male and female 
➢ Depressed mood 
➢ Reduced level of interest 
➢ Considerable loss or gain of weight 
➢ Insomnia or hypersomnia 
➢ Psychomotor agitation or retardation 
➢ Fatigue 
➢ Thoughts of extreme guilt 
➢ Diminished ability to think or concentrate 
➢ Suicidal thoughts 
➢ Willing to participate in trial and signing consent by fulfilling the conditions of 
proforma                       
➢ Willing to give blood sample for analysis for laboratory investigations 
(If 8 – 10 criteria are positive, the patients will be included for the study) 
EXCLUSION CRITERIA 
➢ Pregnancy and lactation 
➢ Diabetes mellitus 
➢ Psychosomatic disorders 
➢ Cardiac disease 
➢ Any other serious systemic illness 
WITHDRAWAL CRITERIA 
➢ Intolerance to the drug and development of adverse reactions during drug trial. 
➢ Poor patient compliance and defaulters. 
➢ Patient turning unwilling to continue in the course of clinical trial. 
➢ Occurrence of any serious illness 
➢ Increase in the severity of the symptoms. 
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TESTS AND ASSESMENTS 
            1. Clinical assessment  
2. Siddha system assessment 
3. Routine investigations 
1. CLINICAL ASSESMENT 
➢ Depressed mood 
➢ Reduced level of interest 
➢ Considerable loss or gain of weight 
➢ Insomnia or hypersomnia 
➢ Anhedonia 
➢ Fatigue 
➢ Thoughts of extreme guilt 
➢ Suicidal thoughts 
GRADATION 
HAMILTON DEPRESSION RATING SCALE (HAM-D) 
The Hamilton Depression Rating Scale (HAM-D) has proven useful for many years as 
a way of determining a patient’s level of depression before, during, and after treatment. It 
should be administered by a clinician experienced in working with psychiatric patients. 
Although the HAM-D form lists 21 items, the scoring is based on the first 17. It 
generally, takes 15-20 minutes to complete the interview and score the results. Eight items are 
scored on a 5-point scale, ranging from 0 = not present to 4 = severe. Nine 
are scored from 0-2. 
Since its development in 1960 by Dr. Max.Hamilton of the University of Leeds, 
England, the scale has been widely used in clinical practice and become a standard in 
pharmaceutical trials. 
HAMILTON DEPRESSION RATING SCALE (HAM-D)” 
Patient’s Name  
Date of Assessment  
To rate the severity of depression in patients who are already diagnosed as depressed, 
administer this questionnaire.  The higher the score, the more severe the depression.  
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For each item, write the correct number on the line next to the item.  (Only one 
response per item)  
1. DEPRESSED MOOD (Sadness, hopeless, helpless, worthless)  
0= Absent  
1= These feeling states indicated only on questioning  
2= These feeling states spontaneously reported verbally  
3= Communicates feeling states non-verbally—i.e., through facial expression, 
posture, voice, and tendency to weep  
4= Patient reports VIRTUALLY ONLY these feeling states in his spontaneous verbal 
and non- verbal communication  
2. FEELINGS OF GUILT  
0= Absent  
1= Self-reproach, feels he has let people down  
2= Ideas of guilt or rumination over past errors or sinful deeds  
3= Present illness is a punishment.  Delusions of guilt  
4= Hears accusatory or denunciatory voices and/or experiences threatening visual 
hallucinations  
3. SUICIDE  
0 = Absent  
1 = Feels life is not worth living  
2 = Wishes he were dead or any thoughts of possible death to self  
3 = Suicidal ideas or gesture  
4 = Attempts at suicide (any serious attempt rates 4)  
4. INSOMNIA EARLY  
0 = No difficulty falling asleep  
1 = Complains of occasional difficulty falling asleep—i.e., more than 1/2 hour  
2 = Complains of nightly difficulty falling asleep  
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5. INSOMNIA MIDDLE  
0=  No  difficulty  
1=  Patient  complains  of  being  restless  and  disturbed  during  the  night  
2=  Waking  during  the  night—any  getting  out  of  bed  rates  2  (except  for   
purposes  of  voiding) 
6. INSOMNIA LATE  
0= No difficulty  
1=  Waking  in  early  hours  of  the  morning  but  goes  back  to  sleep  
2=  Unable  to  fall  asleep  again  if  he  gets  out  of  bed  
7. WORK AND ACTIVITIES  
0=  No  difficulty  
1=  Thoughts  and  feelings  of  incapacity,  fatigue  or  weakness  related  to  
activities;  work  or hobbies  
2=  Loss  of  interest  in  activity;  hobbies  or  work—either  directly  reported  by  
patient,  or indirect  in  listlessness,  indecision  and  vacillation  (feels  he  has  to  
push  self  to  work  or activities)  
3=  Decrease  in  actual  time  spent  in  activities  or  decrease  in  productivity  
4=  Stopped  working  because  of  present  illness 
8.RETARDATION:  PSYCHOMOTOR  (Slowness  of  thought  and  speech;  impaired  
ability to  concentrate;  decreased  motor  activity)  
0=  Normal  speech  and  thought  
1=  Slight  retardation  at  interview  
2=  Obvious  retardation  at  interview  
3=  Interview  difficult  
4=  Complete  stupor  
9. AGITATION  
0=  None  
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1=  Fidgetiness  
2=  Playing  with  hands,  hair,  etc.  
3=  Moving  about,  can't  sit  still  
4=  Hand  wringing,  nail  biting,  hair-pulling,  biting  of  lips  
10. ANXIETY (PSYCHOLOGICAL)  
 0=  No  difficulty  
1=  Subjective  tension  and  irritability  
2=  Worrying  about  minor  matters  
3=  Apprehensive  attitude  apparent  in  face  or  speech  
4=  Fears  expressed  without  questioning 
11.    ANXIETY  SOMATIC:  Physiological  concomitants  of  anxiety,  (i.e.,  effects  of  
autonomic overactivity,  "butterﬂies,"  indigestion,  stomach  cramps,  belching,  diarrhea,  
palpitations, hyperventilation,  paresthesia,  sweating,  ﬂushing,  tremor,  headache,  urinary  
frequency). Avoid  asking  about  possible  medication  side  effects  (i.e.,  dry  mouth,  
constipation)  
0=  Absent  
1=  Mild  
2=  Moderate  
3=  Severe  
4=  Incapacitating  
12.    SOMATIC SYMPTOMS (GASTROINTESTINAL)  
0=  None  
1=  Loss  of  appetite  but  eating  without  encouragement  from  others.  Food  intake 
about  normal  
2=  Difficulty  eating  without  urging  from  others.  Marked  reduction  of  appetite  
and food  intake  
13.    SOMATIC SYMPTOMS GENERAL  
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0=  None  
1=  Heaviness  in  limbs,  back  or  head.  Backaches,  headache,  muscle  aches.  Loss  
of  energy and  fatigability  
2=  Any  clear-cut  symptom  rates  2  
14.    GENITAL  SYMPTOMS  (Symptoms  such  as:  loss  of  libido;  impaired  sexual  
performance; menstrual  disturbances)  
0=  Absent  
1=  Mild  
2=  Severe  
15.    HYPOCHONDRIASIS  
0=  Not  present  
1=  Self-absorption  (bodily)  
2=  Preoccupation  with  health  
3=  Frequent  complaints,  requests  for  help,  etc.  
4=  Hypochondriacal  delusions  
16.    LOSS OF WEIGHT  
A.  When  rating  by  history:  
0=  No  weight  loss  
1=  Probably  weight  loss  associated  with  present  illness  
2=  Definite  (according  to  patient)  weight  loss  
3=  Not  assessed  
17.    INSIGHT  
0=  Acknowledges  being  depressed  and  ill  
1=  Acknowledges  illness  but  attributes  cause  to  bad  food,  climate,  overwork,  
virus,  need for  rest,  etc.  
2=  Denies  being  ill  at  all  
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18.    DIURNAL VARIATION  
A.  Note whether symptoms are worse in morning or evening. If NO diurnal variation, 
mark none  
0=  No  variation  
1=  Worse  in  A.M.  
2=  Worse  in  P.M.  
B.  When  present,  mark  the  severity  of  the  variation.  Mark  "None"  if  NO  
variation   
0=  None  
1=  Mild  
2=  Severe  
19.    DEPERSONALIZATION AND DEREALIZATION (Such as:  Feelings of unreality; 
Nihilistic ideas)  
0=  Absent  
1=  Mild  
2=  Moderate  
3=  Severe  
4=  Incapacitating  
20.    PARANOID SYMPTOMS  
0=  None  
1=  Suspicious  
2=  Ideas  of  reference  
3=  Delusions  of  reference  and  persecution  
21.    OBSESSIONAL AND COMPULSIVE SYMPTOMS  
0=  Absent  
1=  Mild  
2=  Severe 
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HAM-D Scoring Instructions: 
Sum the scores from the first 17 items. 
• 0-7 = Normal 
• 8-13 = Mild Depression 
• 14-18 = Moderate Depression 
• 19-22 = Severe Depression 
• ≥ 23 = Very Severe Depression 
Hamilton, M: A rating scale for depression, Journal of Neurology, Neurosurgery, and 
Psychiatry 23:56-62, 1960 
2.INVESTIGATIONS BASED ON SIDDHA SYSTEM: 
1. Naadi 
2. Sparisam 
3. Naa 
4. Niram 
5. Mozhi 
6. Vizhi 
7. Malam 
      8.Moothiram 
               ● Neerkkuri:    ● Neikkuri: 
3.INVESTIGATION: 
BLOOD: 
• Hb 
• Total WBC Count 
• DC 
▪ Polymorphs 
▪ Lymphocytes  
▪ Eosinophils 
▪ Monocytes  
▪ Basophils  
• Total RBC count  
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• ESR 
▪ ½ Hr:                   1 Hr: 
• Blood sugar 
▪ Fasting:    PP: 
• Serum cholesterol 
URINE 
• Albumin 
• Sugar(F)                          (PP) 
• Deposits 
RENAL FUNCTION TESTS 
• Blood Urea 
• Serum Creatinine 
• Uric acid 
LIVER FUNCTION TESTS 
• Serum total bilirubin 
• Direct bilirubin 
• Indirect bilirubin 
• Serum Alkaline phosphatases 
• SGOT 
• SGPT  
PRIMARY OUTCOME: 
• Reduction in the symptoms of Depression. 
DATA COLLECTION: 
Required information were collected from each patient by using the following forms 
FORMS:  
• FORM I          -   Screening and selection Proforma 
• FORM II         -  Clinical assessment Proforma 
• FORM III        - Laboratory investigation Proforma 
• FORM IV        - Drug compliance form  
• FORM V         - Patient information sheet 
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• FORM VI        - Consent form 
• FORM VII       - Withdrawal form/Pharmacovigilance 
• FORM VIII     - Dietary Advice form 
STUDY ENROLLMENT: 
➢ In this study, patients reporting at the OPD with symptoms of depressed mood, fatigue, 
loss of interest, suicidal thoughts, insomnia, hypersomnia were examined clinically for 
enrolling in the study based on inclusion and exclusion criteria.  
➢ The patients who are enrolled were informed (Form VI) about the study, trial drug, 
possible outcomes and the objectives of the study in the language and terms 
understandable to them and the informed consent would be obtained in writing from 
them in the consent form (Form VI).  
➢ All these patients were given unique registration card in which the patients Registration 
number of the study, Address, Phone number and Doctors phone number etc. will be 
given, so as to report easily should any complications arise. 
➢ Complete clinical history, complaints, duration, examination findings and laboratory 
investigations -- were recorded in the prescribed Proforma. 
➢ Screening Form- I were filled up: Form –II and Form –III were used for recording the 
patient’s history, clinical examination of symptoms, signs and laboratory investigations 
respectively. Patients were advised to take the trial drug and appropriate dietary advice 
would be given according to the patients’ perfect understanding. 
CONDUCT OF THE STUDY: 
➢ Three days before the treatment, purgation therapy had given with Meganatha Kulikai- 
2 in the early morning with Inji chaaru (ginger juice) for normalising the vital humours. 
Then the trial Medicines “Thirutharakchatha chooranam” (internal) and “Aruganver 
Thylam” (external) was given for 48 days.   
➢ Among the 30 patients, 15 patients were received trial the medicines only and the 
remaining (randomised) 15 patients were received the prescribed Yogam therapy along 
with trial medicines.      
➢ The patients are requested to visit the hospital OPD once in 7 days for 48 days. In each 
and every visit the patients received trial medicines and also underwent clinical 
assessment and the prognosis were recorded with the supervision of the Faculty 
member.    
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➢ The each randomised selected 15 patients (2,5,7,8,10,13,14,18,19,21,23,26,27,29,30) 
were received the Yogam theraphy for 3 times per week from the 2nd visit for the trial 
medicine to 7th visit.   
➢  Laboratory investigations were done before and after the trial. At the end of the trial, 
the patients were advised to visit the OPD for further 2 months for follow-up for any 
recurrence. Defaulters had not allowed to continue and withdrawn from the study with 
fresh case had being inducted. 
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INFORMED CONSENT FORM 
ADVERSE REACTION 
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TREATMENT IN OPD 
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PHARMACOVIGILANCE 
DEPARTMENT 
FURTHER MANAGEMENT OF 
ADVERSE DRUG REACTION 
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ADVERSE/SERIOUS EFFECTS MANAGEMENT: 
➢ In this study, no adverse events were observed during the course of the treatment and 
follow-up periods. 
DATA ANALYSIS: 
➢ After enrolled the patients in the study, a separate file for each patient was maintained 
and all forms were kept in the file.  
➢ Study number and patient’s number were entered on the top of the file for easy 
identification.  
➢ Whenever the patients visit to OPD during the study period, the necessary entries were 
made at the assessment forms.   
➢ The screening forms were filled separately.  
➢ All forms were further scrutinized by Senior Research Officer (Statistics) for logical 
errors and incompleteness of data to avoid any bias.  
➢ No modification in the results is permitted for unbiased reports. The software of SPSS 
will be used for data analysis.     
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RESULTS OF PRECLINICAL STUDY: 
1) BIO-CHEMICAL AND ELEMENTAL ANALYSIS OF TRIAL MEDICINE  
Qualitative Analysis 
S.NO EXPERIMENT OBSERVATION INFERANCE 
1. Appearance of the sample Greenish Brown in 
Colour  
 
 
2. Solubility 
 a. A little of the sample is shaken 
well with distilled water. 
 b. A little of the sample is Shaken 
well with con. Hcl Con. H2SO4.  
 
Completely soluble 
 
 
Completely soluble 
Absence of Silicate 
3. Action of Heat 
         A small amount of the sample 
is taken in a dry test tube and heated 
gently at first and then Strong.  
 
White fumes not 
evolved Brown 
fumes not evolved  
                     
Absence of 
Carbonate.                        
Absence of Nitrate 
4. Flame Test 
          A small amount of the sample 
is made into a paste with con. Hcl in 
a watch glass and introduced into 
non-luminous part of the Bunsen 
flame.  
 
White flame is 
appeared 
Absence of Copper 
5. Ash Test 
          A filter paper is soaked into a 
mixture of sample and cobalt nitrate 
solution and introduced into the 
Bunsen flame and ignited 
No Yellow colour 
flame 
Absence of Sodium. 
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PREPARATION OF EXTRACT 
           5 gm of THIRUTHARAKCHATHA CHOORANAM was weighed accurately and placed 
in a 250 ml clean beaker. Then 50 ml distilled water was added and dissolved well. Then it is 
boiled well for about 10 minutes. It was cooled and filtered in a 100 ml volumetric flask and 
then it was made up to 100 ml with distilled water. This fluid was taken for analysis.  
1.TEST FOR ACID RADICALS: 
S.NO EXPERIMENT OBSERVATION INFERENCE 
1. Test for Sulphate:  
a. 2 ml of the above prepared 
extract is taken in a test tube to 
this added 2ml of 4% ammonium 
oxalate solution. 
 b. 2ml of the above prepared 
extract is added with 2 ml of 
dilHcl is added until the 
effervescence ceases off. Then 
2ml of Barium chloride solution is 
added.  
Cloudy appearance 
present  
  
A white precipitate 
insoluble in con. Hcl 
is obtained 
presence of sulphate 
2. Test for Chloride: 
       2 ml of the above prepared 
Extract is added with dil. HNO3 
till the effervescence ceases. Then 
2 ml of silver nitrate solution is 
added.  
No Cloudy 
appearance present 
(Mild trace element)  
 
Absence of chloride 
3. Test for Phosphate: 
         2 ml of the extract is treated 
with 2ml of ammonium 
molybdate solution and 2 ml of 
con. HNO3 
Cloudy yellow 
appearance  
 
Presence of 
phosphate 
4. Test for Carbonate:  cloudy appearance Presence of 
Carbonate. 
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         2m1 of the extract is treated 
with 2ml magnesium sulphate 
solution 
5. Test for Nitrate:  
1gm of the substance is heated 
with copper turnings and 
concentrated H2SO4   and viewed 
the test tube vertically down. 
Brown gas is not 
evolved  
  
 
Absence of nitrate 
6. Test for Sulphide:  
1 gm of the substance is treated 
with 2m1 of con. Hcl. 
No rotten egg 
smelling gas evolved 
Absence of sulphide 
7. Test for Fluoride and oxalate: 
2 m1 of The Extract Is Added 
With 2m1of Acetic Acid and 2 
m1 calcium Chloride solution and 
heated.  
No cloudy appearance  Absence of fluoride 
and oxalate 
 
 
8. Test for Nitrate:   
 3 drops of extract is placed on a 
filter paper, on that 2 drops of 
acetic Acid and 2 drops of 
benzidine solution is placed. 
No characteristic 
changes 
Absence of nitrate 
9. Test for Borate:    
  2 pinches of the substance are 
made into paste by using 
sulphuric acid and alcohol (95%) 
and introduced into the blue flame 
 Absence of borate 
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II. TEST FOR BASIC RADICALS 
S.no EXPERIMENT OBSERVATION INFERENCE 
1. Test for Lead: 
        2 m1of the extract is added 
with 2m1of potassium iodide 
solution.  
No Yellow precipitate 
is obtained  
 
Absence of Lead. 
2. Test for Copper:  
       a. One pinch of substance is 
made into paste with con. Hcl in a 
watch glass and introduced into the 
non-luminous part of the flame. 
 b. 2 ml of extract is added with 
excess of ammonia solution.  
 Blue colour flame 
precipitate  
  
  
No Blue colour 
precipitate   
 
Presence of Copper.  
  
  
  
Absence of Copper. 
3. Test For Aluminium: 
        Take the 2m1of the extract 
sodium hydroxide is added in drops 
to excess. 
No characteristic 
changes  
 
Absence of 
Aluminium. 
4. Test  For  Iron (Ferrous) : 
      To the 2 ml of extract 2m1                                         
ammonium thiocyanate solution  
and 2m1of con.HNO3 is added.  
Blood red colour 
Appearance
Presence of Iron. 
5. Test For Zinc:  
          To 2m1 of the extract sodium 
hydroxide solution is added in 
drops to excess. 
White precipitate is 
not Formed  
 
Absence of Zinc.  
 
6. Test For Calcium:  
        To  2m1 of the extract is 
added with 2m1 of 4% ammonium 
oxalate Solution.  
Cloudy appearance 
and white precipitate                       
is obtained  
 
Presence of Calcium 
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7. Test For Magnesium:   
     To 2ml of extract sodium                                   
hydroxide solution is added in 
drops to excess.  
White precipitate is 
not obtained.  
 
Absence of 
Magnesium 
8. Test For Ammonium:  
          To 2ml of extract few ml of 
Nessler's reagent and excess of 
sodium hydroxide solution are 
added 
No brown colour 
appeared 
Absence of 
Ammonium 
9. Test For Potassium:   
            A pinch of substance is 
treated with 2ml of sodium nitrite 
solution and then treated with 
2m1 of cobalt nitrate in 30% 
glacial acetic acid. 
Yellowish precipitate 
is obtained  
 
Presence of 
pottassium 
 
10. Test For Sodium:  
      2 pinches of the substance is 
made into paste by using HCL 
and introduced into the blue flame 
of Bunsen burner. 
No Yellow Color 
Flame appeared.  
 
Absence of Sodium. 
11. Test For Mercury:  
      2 m1 of the extract is treated 
with 2ml of sodium hydroxide 
solution.  
Yellow precipitate                           
is not obtained  
 
Absence of Mercury.  
 
12. For Arsenic Test: 2 m1 of the 
extract is treated with 2m1 of 
sodium hydroxide solution. 
No brownish red 
Precipitate is obtained  
 
Absence of Arsenic. 
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III. MISCELLANEOUS: 
S.NO EXPERIMENT OBSERVATION INFERENCE 
1. Test for Starch: 
         2 ml of extract is treated 
with weak iodine solution.  
blue colour developed  
 
Presence of Starch.  
 
2. Test For Reducing Sugar:   
            5 ml of Benedict's 
qualitative solution is taken in a 
test tube and allowed to boil for 2 
minutes and added 8 to 10 drops 
of the extract and again boil it for   
2 minutes. The colour changes are 
noted.   
 Brick red colour 
developed  
 
Presence  of 
Reducing sugar.  
 
3. Test For The Alkaloids:  
a. 2m1 of the extract is treated 
with 2 ml of potassium Iodide 
solution.                       b. 2m1 of 
extract is treated with 2ml of 
picric acid. c. 2m1 of the extract is 
treated with 2ml of 
phosphotungstic acid. 
Red colour developed  
 Trace Yellow colour 
developed White 
precipitate developed  
  
 
Presence of 
Alkaloid.  
  
Trace of Alkaloid 
present. Presence of 
Alkaloid. 
4. Test for Tannic Acid:  2 ml of 
extract is treated with  2ml of 
ferric chloride solution. 
Black precipitate is 
obtained  
 
Presence of tanin 
5. Test for Unsaturated Compound:     
To the 2ml of extract 2ml of 
Potassium Permanganate solution 
is added.  
Potassium 
Permanganate is not 
decolourised 
Absence  of 
Unsaturated 
Compound. 
6. Test For Amino Acid:    
      2 drops of the extract is placed 
on a filter paper and dried well 
and 2 ml of biuret reagent is 
added . 
No Violet colour 
developed  
 
Absence of Amino 
acids 
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7. Test For type of Compound:   2ml 
of the extract is treated with 2 ml 
of ferric chloride solution. 
Green colour 
developed  
  
  
No Red colour 
developed  
  
  
  
No Violet colour 
developed  
  
  
No blue colour  
developed  
 
Presence of oxy 
quinole epinephrine 
and pyro catechol.  
  
Anti pyrine, 
Aliphatic          
amino acids and 
Meconic acid are 
absent.  
  
Apomorphine, 
Salicylate and 
Resorcinol are 
absent.  
  
Morphine, Phenol 
cresol and hydro 
quinone are absent 
    
Result: 
            The bio chemical analysis of Thirutharakchatha chooranam shown the presents of 
sulphate, phosphate, carbonate, copper, aluminium, iron, calcium, potassium, starch, reducing 
sugar, alkaloids, tannic acid. 
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     OBSERVATION AND RESULTS CLINICAL STUDY 
 The observation and results were studied and tabulated under the following heading.  
➢ Age and sex 
➢ Occupational Status  
➢ Family History  
➢ Diet Habits  
➢ Thinai Reference  
➢ Kaalam Distribution 
➢ Yakkai Ilakkanam (Physical Constitution)  
➢ Gunam  
➢ Duration of Illness  
➢ Distributions of MuthThodam (Three Humours)  
➢ Udal Kattukkal   
➢ En Vagai Thervugal  
➢ Neerkkuri, Neikkuri   
➢ Haematology General report  
➢ Haematology Biochemistry report  
➢ Urine Analysis   
➢ Result and Statistical Significance of HAM-D score 
➢  Result and Statistical Significance of yogam 
➢ Result and Statistical significance of trail medicine. 
 
depression
no of cases 
screened
128
no of cases 
enrolled
35
no of cases 
included 30
no of cases 
excluded
93
no of cases 
withdrawal 
5
adverse effect
reported 
0
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1. Age Distribution: 
S.NO AGE NO OF CASES PERCENTAGE 
1. 20-25 5 16.6% 
2. 26-35 17 56.6% 
3. 36-45 7 23.3% 
4. 46-55 1 3.3% 
 
                   
 Observation:    The patients were selected from all age groups as given above and the 
maximum numbers of patients 17(56.6%) were in the age groups between 26-35.  
2. Sex: 
S.NO SEX NO OF CASES PERCENTAGE 
1. Female 13 43.3% 
2. Male 17 56.6% 
 
 
0
5
10
15
20
20-25 26-35 36-45 46-55
AGE
13, 43%
17, 57%
SEX
Female
Male
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Observation:Among the 30 patients selected for this study, 57% were males and 43% were 
females.   
3.Occupational: 
S.NO NATURE OF WORK NO OF CASE PERCENTAGE 
1. Students  2 6.6% 
2. Workers  15 50% 
3. Home maker  9 30% 
4. Un employed   4 13.3% 
 
 
Observation:   The majority of patients in this study were workers, homemaker, unemployed 
and students.  
4.Family history: 
S.NO CRITERIA NO OF CASE PERCENTAGE 
1. Family History (Relevant)          22 73.3% 
2. Family History (No relevant) 8 26.6% 
 
2
15
9
46.60% 50% 30% 13.30%
STUDENTS WORKERS HOME MAKER UN EMPLOY  
NATURE OF WORK
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Observation:  In this study,22 number (73.3%) of cases had positive family history. 
5.Dietary habits: 
S.NO Dietary habits NO OF CASE PERCENTAGE 
1. Vegetarian 3 10% 
2. Non-vegetarian 27 90% 
 
                                           
 
Observation: In this study only 90% of Patients were Non. Vegetarian. 
6. Thinai reference: 
S.NO THINAI NO OF CASE PERCENTAGE 
1. Kurinji (Hill Area)   0 0% 
2.  Mullai (Forest Area) 0 0% 
3.  Marutham (Fertile Land)  4 13.3% 
0
5
10
15
20
25
NO OF CASE
family history 
Family History (Relevant) Family History (No relevant)
97%
3%
DIATERY HABITS
NO OF CASE
PERCENTAGE
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4.  Neithal (Coastal Area)  26 86.6% 
5.  Paalai (Desert Land) 0 0% 
 
                                    
Observation:      In this study 86.6% of the patients were from neithal, 13.3%% were from 
marutham. 
7.KALAM DISTRIBUNCE: 
S.NO KALAM NO OF CASE PERCENTAGE 
1. Kaar kaalam   0 0% 
2. Koothir kaalamn 3 10% 
3.  Munpani kaalam 12 40% 
4.   Pinpani kaalam 14 46.6% 
5. Elavenil kaalam   2 6.6% 
6. Muthuvenil kaalam 0 0% 
 
 
 
 
 
 
 
 
THINAI
Kurinji (Hill Area)
 Mullai (Forest Area)
 Marutham (Fertile
Land)
 Neithal (Coastal
Area)
0 3
12
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Observation:   Among 30 patients, 65% of patients were comes in Pinpani kaalam 46.6% 
and 40% 0f patients comes in munpani kaalam and 10% of patients in koothir kaalam. 
8. Yaakai Ilakkanam (Physical Constitution): 
S.NO YAKKAI 
ILAKKANAM 
NO OF CASE PERCENTAGE 
1. Vadha udal  0 0% 
2. Pitha udal  0 0% 
3. Kapha udal  0 0% 
4. Thontha udal  30 100% 
 
 
 
 
 
 
  
 
Observation:   All the patients (100%) had ThonthaUdal 
9. Gunam (Quality and Characters): 
S.NO GUNAM NO OF CASE  PERCENTAGE 
1. Sathuva gunam -  
2. Rajo gunam  30 100% 
3. Thamo gunam  -  
 
 
 
 
0%
50%
100%
Vadha udal Pitha udal Kapha udal Thontha udal
YAKKAI ILAKKANAM
NO OF CASE PERCENTAGE
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Observation:  All of the patients 30(100 %) had “Rajo Gunam” 
10. Duration of Illness: 
S.NO DURIATION OF 
ILLNESS 
NO OF CASE  PERCENTAGE  
1. Below one year 9 30% 
2. Above 1-2 years 8 26.6% 
3. Above 2-3 years  9   30% 
4. Above 3 years  5 16.6% 
 
                                
Observation:    Among 30 patients 30% of cases were suffering in the duration of below one 
year and 2-3 year, 26.6% of cases suffering in the duration of 1-2year, 16.6% were in the 
duration of above 3 years. 
11.Distribution of Mukkutram: 
 The derangements of Vatham, Piththam and Kabam in viyagula unmatham are as follows  
0%
20%
40%
60%
80%
100%
- 30 -
Sathuva gunam Rajo gunam Thamo gunam
GUMAM
DURIATION OF ILLNESS 
Below one year
Above 1-2 years
Above 2-3 years
Above 3 years
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VATHAM: 
S.NO CLASSIFICATION OF 
VATHAM 
NO OF CASE PERCENTAGE 
1. Pranan  30 100% 
2. Abanan  20 66.6% 
3. Udhanan  0 0% 
4. Samanan  0 0% 
5. Viyanan  0 0% 
6. Naagan  30 100% 
7. Koorman  10 33.3% 
8. Kirukaran  0 0% 
9. Devathaththan  30 100% 
10. Danajeyan 0 - 
Observation:  Among the 30 cases, pranan, naagan, devathathan were 100% affected, 65.6% 
cases were affected abanan and 33.3% cases were affected koorman. 
PITHAM: 
S.NO CLASSIFICATION OF 
MPITHA  
NO OF CASE PERCENTAGE 
1. Analagam  0 0% 
2. Ranjagam  0 0% 
3. Sadhagam  30 100% 
4. Prasagam  0 0% 
5. Alosagam  0 0% 
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Observation:  All of the patients 30(100 %) had “sadhagam” affected 
KAPHAM: 
S.NO CLASSIFICATION OF 
KAPHAM 
NO OF CASES PERCENTAGE 
1. Avalambagam  0 0% 
2. Kilethagam  0 0% 
3. Tharpagam  0 0% 
4. Pothagam  0 0% 
5. Santhigam  16 53.3% 
Observation: Among the 30 patients, santhigam were affected 53.3%. 
12. UDAL KATTUGAL: 
S.NO UDAL KATTUGAL  NO OF CASE  PERCENTAGE 
1. Saram  30 100% 
2. Seneer  0 0% 
3. Oon  20 66.6% 
4. Kozhupu 0 0 
5. Enbu  0 0 
6. Moolai  0 0 
7. Sukkilam/suronitham  10 33.3% 
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Observa tion:  Among 30 patients, Saaram, oon and sukkilam, suronitham were affected in 
all the cases. 
13. EN VAGAI THERVUGAL: 
S.NO ENVAGAI 
THERVUGAL 
NO OF CASE PERCENTAGE 
1. NAADI:   
Vatha pitham 14 46.6% 
Pitha vatham 16 53.3% 
Kapha pitham 0 0% 
Kapha vatham 0 0% 
2. Sparisam  0 0% 
3. Naa  0 0% 
4. Niram  0 0% 
5. Mozhi  0 0% 
6. Vizhi  6 20% 
7. Malam  20 66.6% 
8th examination discussed separately. 
50%
0%
33%
0%
17%
UDAL KATTUGAL 
Saram
Seneer
Oon
kozhupu
Enbu
Moolai
Sukkilam/suronitham
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Obsrvation:  In Envagai thervugal, the Naadinadai seen in Viyagula unmatham patients were 
Pithavaatham was affected in 16 (53.3(%), Vaathapitham was affected in 14 (46.6 %), malam 
were affected in 20(66.6%) cases.  The rest of the other elements of Envagai thervukal were 
not affected.   
14.NEER KURI & NEI KURI:  
A. NEERKURI: 
S.NO TYPE OF TEST NO OF CASE PERCENTAGE 
1. Niram (pale yellow) 30 100% 
B.NEI KURI: 
S.NO TYPE OF TEST NO OF CASE PERCENTAGE 
1. Vatham (aravena 
neendathu) 
12 40% 
2. Pitham (aazhi poi 
paraviyathu) 
14 46.6% 
3. Kapham (muththothu 
nindrathu) 
4 13.3% 
  
0
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ENVAGAI THERVUGAL 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT(HEMATOLOGY) 
S. 
No 
 OP.   
No. 
Age/Sex Hb (gm/dl) Total RBC count 
(million/cu.mm) 
ESR 
(mm/hr) 
Total WBC 
(cells/cu.mm) 
BT  AT     BT    AT BT AT   BT   AT 
1. J24573 36/M 13.0 13.2 4.7 4.8 10/22 10/22 9400 9800 
2. J18597 43/M 11.4 11.2 4.1 4.0 10/20 10/20 9000 9000 
3. J20109 20/F 12.7 12.1 4.9 4.8 10/22 10/22 8400 9000 
4. J16543 29/M 16.1 16.0 6.2 5.9 2/4 2/4 5500 5200 
5. J30889 30/F 13.1 13.3 4.3 4.5 8/16 6/14 6100 7500 
6. J65938 26/F 10.2 10.4 4.0 4.1 16/32 16/32 6500 6300 
7. J63427 45/M 15.5 13.8 5.2 4.8 4/8 10/22 5300 9200 
8. G61704 21/F 13.1 13.2 4.9 4.9 4/10 4/8 8400 10200 
9. J80464 33/F 12.6 11.7 4.1 3.9 14/30 14/30 7200 7600 
10. J89702 25/M 15.1 14.1 5.0 5.2 2/4 4/8 5100 10000 
11. J86767 45/F 12.4 12.0 4.2 4.0 12/26 10/20 4500 4500 
12. J45831 38/M 13.7 13.8 5.1 5.2 4/8 4/8 4600 4800 
13. J89037 36/M 13.6 13.8 5.0 5.1 4/10 4/10 12100 12100 
14. J91207 42/M 14.5 14.1 4.9 4.8 6/14 6/12 7700 7800 
40%
47%
13%
NEIKURI
1 Vatham (aravena neendathu) 2 Pitham (aazhi  poi paraviyathu)
3 Kapham (muththothu nindrathu)
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15. J27240 24/M 15.4 15.1 5.3 5.2 2/4 2/4 5500 5200 
16. J97649 55/F 13.9 13.4 5.1 5.9 6/12 6/12 9000 9000 
17. K00391 33/F 12.0 118 4.7 4.7 30/66 30/66 14000 11500 
18. J99581 35/F 13.9 14.5 5.0 5.1 4/12 4/8 8500 10300 
19. K00384 27/M 14.7 14.3 4.9 4.8 4/8 10/22 6100 6300 
20. K01901 35/M 15.2 13.7 5.1 4.5 2/4 4/8 6900 9300 
 
INVESTIGATIONS BEFORE AND AFTER TREATMENT(HEMATOLOGY) 
S. 
No 
 OP no Age/ 
Sex 
Hb (gm/dl) Total RBC 
count 
(million/ 
cu.mm) 
ESR 
(mm/hr) 
Total WBC 
(cells/cu.mm) 
  BT AT   BT AT  BT AT   BT   AT 
21. H81102 43/F 11.0 9.5 4.1 3.6 30/62 30/66 8400 7000 
22. K12855 28/M 13.9 14.2 4.4 4.7 2/4 16/32 10700 8000 
23. K07097 25/F 12.3 12.4 4.6 4.6 10/22 10/22 9100 8900 
24. J56993 30/M 15.0 14.4 5.2 5.0 16/34 16/32 8400 6600 
25. K13418 33/F 13.3 13.9 4.5 4.8 10/22 10/22 9200 5200 
26. I96488 27/M 14.3 14.2 4.8 4.8 4/8 4/8 9400 9000 
27. J92947 32/M 14.4 14.7 5.0 5.2 4/8 4/8 6800 7400 
28. K12113 30/F 12.4 12.8 4.0 4.2 20/42 22/42 8800 9000 
29. K15768 26/M 13.7 15.5 4.5 4.8 30/66 4/8 8600 10200 
30. K03174 40/M 13.7 13.8 4.7 4.2 30/62 30/66 5700 5200 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT (LIVER FUNCTION TEST) 
S.No  OP. No Age/ 
Sex 
SGOT SGPT Alkaline phosphatase 
  BT   AT    BT    AT BT AT 
1. J24573 36/M 20 16 14 11 72 60 
2. J18597 43/M 15 20 07 17 40 68 
3. J20109 20/F 07 10 10 12 88 93 
4. J16543 29/M 25 28 12 17 59 55 
5. J30889 30/F 12 20 05 25 64 66 
6. J65938 26/F 12 12 06 10 53 64 
7. J63427 45/M 33 30 49 45 50 67 
8. G61704 21/F 26 15 58 21 91 82 
9. J80464 33/F 16 19 17 27 53 51 
10. J89702 25/M 24 23 17 20 50 60 
11. J86767 45/F 22 25 16 16 74 70 
12. J45831 38/M 25 25 33 30 76 80 
13. J89037 36/M 16 30 19 25 57 80 
14. J91207 42/M 18 20 15 18 60 72 
15. J27240 24/M 17 20 15 17 78 82 
16. J97649 55/F 16 13 11 15 98 98 
17. K00391 33/F 18 28 39 24 77 80 
18. J99581 35/F 14 20 18 16 71 75 
19. K00384 27/M 16 17 11 13 60 72 
20. K01901 35/M 14 16 28 28 72 75 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT (LIVER FUNCTION TEST) 
S. No  OP. No Age/Sex SGOT SGPT Alkaline 
phosphatase 
  BT   AT    BT    AT BT AT 
21. H81102 43/F 15 15 30 11 53 49 
22. K12855 28/M 47 16 59 20 58 70 
23. K07097 25/F 13 15 07 11 104 105 
24. J56993 30/M 17 14 20 22 96 87 
25. K13418 33/F 14 21 08 19 71 73 
26. I96488 27/M 16 20 20 43 68 72 
27. J92947 32/M 14 18 20 34 60 57 
28. K12113 30/F 17 16 09 10 50 62 
29. K15768 26/M 22 32 14 28 74 85 
30. K03174 40/M 14 18 19 24 91 82 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT (LIVER FUNCTION TEST) 
S. No  OP. No Age/Sex Total bilirubin Direct bilirubin Indirect bilirubin 
  BT   AT    BT    AT BT AT 
1. J 24573 36/M 0.5 0.5 0.1 0.2 0.3 0.3 
2. J 18597 43/M 0.9 0.8 0.4 0.4 0.5 0.5 
3. J 20109 20/F 0.4 0.4 0.2 0.1 0.2 0.3 
4. J 16543 29/M 0.3 0.4 0.2 0.2 0.1 0.2 
5. J 30889 30/F 0.3 0.4 0.2 0.2 0.1 0.2 
6. J65938 26/F 0.5 0.5 0.2 0.2 0.3 0.3 
7. J63427 45/M 0.5 0.6 0.1 0.1 0.3 0.4 
8. G61704 21/F 0.2 0.3 0.1 0.1 0.1 0.2 
9. J80464 33/F 0.6 0.4 0.2 0.1 0.4 0.3 
10. J89702 25/M 0.9 0.8 0.4 0.4 0.5 0.5 
11. J86767 45/F 0.3 0.4 0.2 0.1 0.1 0.2 
12. J45831 38/M 1.4 1.2 0.6 0.3 0.8 0.6 
13. J89037 36/M 1.7 1.6 0.5 0.4 1.2 0.7 
14. J91207 42/M 2.2 1.2 0.7 0.7 1.5 1.4 
15. J27240 24/M 0.6 0.6 0.3 0.2 0.3 0.2 
16. J97649 55/F 0.7 0.4 0.3 0.1 0.4 0.3 
17. K00391 33/F 0.3 0.4 0.1 0.2 0.2 0.3 
18. J99581 35/F 0.2 0.6 0.1 0.2 0.1 0.1 
19. K00384 27/M 0.5 0.6 0.2 0.1 0.3 0.4 
20. K01901 35/M 0.4 0.5 0.1 0.1 0.3 0.4 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT (LIVER FUNCTION TEST) 
S. No  OP. No Age/Sex Total bilirubin Direct bilirubin Indirect bilirubin 
  BT   AT    BT    AT BT AT 
21. H81102 43/F 0.7 1.0 0.3 0.4 0.4 0.6 
22. K12855 28/M 0.9 0.6 0.4 0.2 0.5 0.4 
23. K07097 25/F 0.8 0.8 0.3 0.3 0.5 0.5 
24. J56993 30/M 0.6 0.6 0.2 0.2 0.4 0.4 
A25. K13418 33/F 0.7 0.7 0.3 0.3 0.4 0.4 
26. I96488 27/M 1.4 1.2 0.4 0.4 0.9 0.8 
27. J92947 32/M 0.7 0.8 0.3 0.3 0.4 0.5 
28. K12113 30/F 0.6 0.7 0.3 0.3 0.3 0.4 
29. K15768 26/M 0.5 0.6 0.1 0.1 0.4 0.3 
30. K03174 40/M 0.4 0.4 0.6 0.5 0.1 0.2 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT (RENAL FUNCTION TEST) 
S. No  OP. No Age/Sex Blood sugar 
Fasting 
Blood sugar 
Post prandial 
urea Creatinine 
  BT  AT   BT   AT BT AT  BT   AT 
1. J 24573 36/M 90 88 124 115 18 15 0.8 1.2 
2. J 18597 43/M 94 90 100 115 25 18 0.7 0.8 
3. J 20109 20/F 100 95 148 135 35 30 0.8 0.8 
4. J 16543 29/M 97 90 96 116 17 20 1.0 1.0 
5. J 30889 30/F 93 81 83 93 11 14 0.9 0.8 
6. J65938 26/F 78 88 95 87 17 15 1.0 0.9 
7. J63427 45/M 105 85 120 110 21 24 1.0 0.8 
8. G61704 21/F 88 92 107 191 19 19 0.8 0.8 
9. J80464 33/F 98 104 104 169 14 13 0.7 0.8 
10. J89702 25/M 89 93 97 118 22 25 0.8 1.0 
11. J86767 45/F 94 85 102 110 14 23 0.8 1.0 
12. J45831 38/M 105 93 93 115 13 20 1.0 0.8 
13. J89037 36/M 107 105 129 127 19 19 0.8 0.7 
14. J91207 42/M 92 95 117 123 11 15 0.9 0.7 
15. J27240 24/M 115 105 117 127 12 15 1.1 0.9 
16. J97649 55/F 97 101 124 130 17 15 0.8 0.7 
17. K00391 33/F 97 104 139 124 20 19 0.9 0.6 
18. J99581 35/F 82 98 106 119 19 24 1.0 0.8 
19. K00384 27/M 88 93 109 125 15 23 1.2 0.9 
20. K01901 35/M 95 83 148 140 27 32 0.9 0.7 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT (RENAL FUNCTION TEST) 
S. No  OP. No Age/Sex blood sugar  
fasting 
Blood sugar 
Post prandial 
Urea Creatinine 
  BT   AT    BT    AT BT AT  BT   AT 
21. H81102 43/F 94 107 98 102 15 16 0.8 0.9 
22. K12855 28/M 116 121 129 115 24 13 1.0 1.1 
23. K07097 25/F 95 86 96 114 13 18 0.8 0.9 
24. J56993 30/M 96 125 124 136 18 21 1.3 1.3 
25. K13418 33/F 95 104 137 104 12 12 0.8 0.9 
26. I96488 27/M 101 111 132 127 21 22 1.1 1.1 
27. J92947 32/M 95 105 128 116 19 16 1.2 1.1 
28. K12113 30/F 101 95 121 115 25 20 0.8 0.7 
29. K15768 26/M 83 90 118 123 39 25 1.1 0.8 
30. K03174 40/M 85 124 96 121 18 25 1.3 0.9 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT (RENAL FUNCTION TEST) 
S. No  OP. No Age 
/Sex 
Urine 
sugar 
fasting 
Urine sugar  
Postprandial 
albumin deposits 
Epithelial  
cells 
Pus cells 
 BT  AT    BT    AT BT AT BT   AT BT  AT 
1. J 24573 36/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
2. J 18597 43/M NIL NIL NIL NIL NIL NIL 1-2 1-2 2-4 1-2 
3. J 20109 20/F NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
4. J 16543 29/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
5. J 30889 30/F NIL NIL NIL NIL NIL NIL 2-4 2-4 1-2 1-2 
6. J65938 26/F NIL NIL NIL NIL NIL NIL 3-5 6-8 3-5 2-4 
7. J63427 45/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
8. G61704 21/F NIL NIL NIL NIL NIL NIL 2-4 1-2 3-5 1-2 
9. J80464 33/F NIL NIL NIL NIL NIL NIL 1-2 2-3 2-3 2-3 
10. J89702 25/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
11. J86767 45/F NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
12. J45831 38/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-3 2-4 
13. J89037 36/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
14. J91207 42/M NIL NIL NIL NIL NIL NIL 1-2 1-3 3-5 1-3 
15. J27240 24/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 1-2 
16. J97649 55/F NIL NIL NIL NIL NIL NIL 1-2 1-3 1-2 1-3 
17. K00391 33/F NIL NIL NIL NIL NIL NIL 2-4 2-4 2-4 2-4 
18. J99581 35/F NIL NIL NIL NIL NIL NIL 2-3 2-4 2-4 1-2 
19. K00384 27/M NIL NIL NIL NIL NIL NIL 1-2 1-3 1-2 1-2 
20. K01901 35/M NIL NIL NIL NIL NIL NIL 1-2 1-2 4-6 3-4 
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INVESTIGATIONS BEFORE AND AFTER TREATMENT (RENAL FUNCTION TEST) 
S. No  OP. No Age/Sex Urine 
sugar 
fasting 
Urine 
sugar 
Post 
prandial 
albumin deposits 
Epithelial  
cells 
Pus 
cells 
 BT  AT  BT  AT BT AT BT AT BT   AT 
21. H81102 43/F NIL NIL NIL NIL NIL NIL 3-5 1-2 1-2 1-2 
22. K12855 28/M NIL NIL NIL NIL NIL NIL 1-2 1-2 3-5 3-5 
23. K07097 25/F NIL NIL NIL NIL NIL NIL 1-2 2-4 1-2 2-4 
24. J56993 30/M NIL NIL NIL NIL NIL NIL 2-4 2-4 2-4 2-4 
25. K13418 33/F NIL NIL NIL NIL NIL NIL 1-2 1-3 2-3 4-6 
26. I96488 27/M NIL NIL NIL NIL NIL NIL 1-2 1-2 2-4 1-2 
27. J92947 32/M NIL NIL NIL NIL NIL NIL 1-2 1-2 1-2 2-4 
28. K12113 30/F NIL NIL NIL NIL NIL NIL 1-3 1-3 1-3 1-2 
29. K15768 26/M NIL NIL NIL NIL NIL NIL 2-4 1-2 2-4 1-2 
30. K03174 40/M NIL NIL NIL NIL NIL NIL 1-4 1-2 3-5 1-4 
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19. RESULTS AND STATISTICAL ANALYSIS: 
All collected data were entered into MS Excel software using different columns as 
variables and rows as patients. SPSS software was used to perform statistical analysis. Basic 
descriptive statistics include frequency distributions and cross-tabulations were performed. The 
quantity variables were expressed as Mean ± Standard Deviation and qualitative data as 
percentage. A probability value of <0.05 was considered to indicate as statistical significance. 
Paired ‘t’ test was performed for determining the significance between before and after 
0treatment.   
 Yogam improvement before and after treatment: 
S.NO OP. NO AGE/SEX BT AT RESULT 
1. J18597 43/M 18 9 Moderate  
2. J 30889 30/F 22 9 Moderate  
3. J63427 45/M 13 8 Moderate  
4. G61704 21/F 16 7 Good  
5. J89702 25/M 13 5 Good  
6. J89037 36/M 12 8 Moderate  
7. J99581 35/F 17 14 Mild 
8. K00384 27/M 16 7 Good  
9. K07097 25/F 16 6 Good  
10. I96488 27/M 12 4 Good  
11. J92947 32/M 16 9 Moderate  
12. K15768 26/M 17 9 Moderate  
13. K03174 40/M 16 9 Moderate  
14. J91207 42/M 18 16 Mild  
15. H81102 43/F 16 6 Good  
 
S.NO RESULTS NO OF CASES PERCENTAGE 
1. Good improvement 6 40% 
2. Moderate improvement 7 46.66% 
3. Mild improvement 2 13.33% 
4. Nil improvement 0 0% 
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statistical significant of yogam Before Treatment and After Treatment: 
 Mean ± SD  t Value p value 
Before treatment 15.87±2.61 9.8885 
 
 
> 0.0001           
After treatment 8.4±3.13    
Observation: The mean± standard deviation of yogam therapy before and after treatment were 
15.87±2.61and8.4±3.13    respectively which is statistically significant 0(> 0.0001).   There is a 
significant difference between before and after treatment on yogam therapy i.e.47.69 % reduction in 
yogam therapy after the trial.    
21.Observation of Trial Medicine before and after treatment: 
S.NO OP. NO AGE/ 
SEX 
BT AT RESULTS 
1. J24573 36/M 18 10 Moderate  
2. J20109 20/F 14 8 Moderate  
3. J16543 29/M 14 10 Moderate  
4. J65938 26/F 16 11 Moderate  
5. J80464 33/F 12 6 Good  
6. J86767 45/F 18 11 Moderate  
7. J45831 38/M 12 9 Moderate  
8. J27240 24/M 16 13 Moderate  
9. J97649 55/F 15 3 Good  
10. K00391 33/F 18 5 Good  
Good improvement
Moderate 
improvement
Mild improvement Nil improvement
YOGAM
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11. K01901 35/M 18 9 Moderate  
12. K12855 28/M 13 2 Good  
13. J56993 30/M 19 14 Mild  
14. K13418 33/F 14 8 Moderate  
15. K12113 30/F 17 14 Mild  
 
S.NO RESULTS NO OF CASES PERCENTAGE 
1. Good improvement 4 26.66% 
2. Modrate improvement 9 60% 
3. Mild improvement  2 13.33% 
4. Nil improvement 0 0% 
 
 
statistical significant of trial medicine(internally&externally) Before Treatment and 
After Treatment: 
 Mean ±SD T value P value 
Before treatment 15.6±2.354 7.9955   > 0.0001 
After treatment 8.866±3.661 
Observation: The mean± standard deviation of medicines before and after treatment were 
15.6±2.354and8.866±3.661   respectively which is statistically significant 0(> 0.0001).   There 
is a significant difference between before and after treatment on trial medicine i.e.43.20 % 
reduction in medicine after the trial. 
4
9
2
TRAIL MEDICINE
Good improvement Modrate improvement Mild improvement Nil improvement
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HAM-D SCORE BEFORE AND AFTER TREATMENT: 
S.NO OP. NO AGE/SEX BT AT RESULTS 
1. J24573 36/M 18 10 Moderate 
2. J18597 43/M 18 9 Moderate 
3. J20109 20/F 14 8 Moderate 
4. J16543 29/M 14 10 Moderate 
5. J 30889 30/F 22 9 Moderate 
6. J65938 26/F 16 11 Moderate 
7. J63427 45/M 13 8 Moderate 
8. G61704 21/F 16 7 Good   
9. J80464 33/F 12 6 Good 
10. J89702 25/M 13 5 Good   
11. J86767 45/F 18 11 Moderate 
12. J45831 38/M 12 9 Moderate 
13. J89037 36/M 12 8 Moderate  
14. J91207 42/M 18 16 Mild  
15. J27240 24/M 16 13 Moderate 
16. J97649 55/F 15 3 Good  
17. K00391 33/F 18 5 Good  
18. J99581 35/F 17 14 Mild 
19. K00384 27/M 16 7 Good  
20. K01901 35/M 18 9 Moderate 
21. H81102 43/F 16 6 Good   
22. K12855 28/M 13 2 Good  
23. K07097 25/F 16 6 Good  
24. J56993 30/M 19 14 Mild  
25. K13418 33/F 14 8 Moderate 
26. I96488 27/M 12 4 Good  
27. J92947 32/M 16 9 Moderate  
28. K12113 30/F 17 14 Mild 
29. K15768 26/M 17 9 Moderate 
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30. K03174 40/M 16 9 Moderate 
 
S.NO RESULTS NO OF CASE PERCENTAGE 
1. Good improvement  
 
10 33.3% 
2. Moderate improvement 
 
16 53.3% 
3. Mild improvement 
 
4 13.3% 
4. Nil improvement 
 
0 0% 
 
 
Paired Sample Statistics (HAM-D Score Before Treatment and After Treatment) :  
     Mean ± SD t Value  p value 
Before treatment 15.60± 2.54   11.4698 >0.0001 
After treatment 8.63±3.36     
Observation The mean± standard deviation of HAM-D score at before and after treatment were 
-15.60± 2.54and8.63±3.36 respectively which is statistically significant 0(> 0.0001).   There is 
a significant difference between before and after treatment on HAM-D Score i.e. 44.68 % 
reduction in HAM-D Score after the tria 
0
5
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HAM-D
RESULTS NO OF CASE PERCENTAGE
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          DISCUSSION 
 The Depression is one of the most important psychological problems more common 
among the population. Majority of them are not seeking the help to proper health care providers 
due to social stigma in related with psychological illness. Large numbers of patients perceive 
even the natural physiological function as abnormal. The Depression is rampant among the 
Indian population and leads to large number of physical and psychological symptoms. Majority 
of these individuals visit self-claimed psychiatrist and traditional faith healers. The contact with 
these health providers not only strengthen their misconception and false beliefs, but also 
compel the patients to pay huge cost of investigations and drugs which are not only non-
effective but also hazardous. This may lead them as a patient in physically and mentally. In 
general practice, most of focus the physicians they attending their patients may missed the 
underlying psychiatric problems. Hence these kinds of patients get more worsened with their 
problems and become a mentally affected patient.      
The trial drugs were prepared in Gunapadam lab of National Institute of Siddha after 
the authentication of the raw drugs by Assistant professor of Medicinal botany NIS, Chennai. 
The trial drug was prepared by Standard Operating Procedure as mentioned in the Protocol.    
The Bio chemical analysis was done at the biochemistry lab of NIS and the results were 
documented. The Bio-chemical analysis of Thirutharakchatha chooranam had shown the 
presence of sulphate, chloride, phosphate, carbonate, calcium, aluminium, zinc, magnesium, 
reducing sugars, iron, tannic acid, starch and alkaloids. The clinical study was conducted with 
a well-defined protocol and a proper proforma after the approval of Institutional Ethical 
Committee. For this dissertation study, 30 patients were selected and patients were treated in 
the OP Department of Sirappu Maruthuvam, in Ayothidoss Pandithar Hospital - National 
Institute of Siddha, Tambaram Sanatorium, Chennai –600 047.  
  Based on various criteria, the data were collected and tabulated. The criteria were 
family history, age distribution, occupation, dietary habits and incidence of the disease with 
reference to thinai, seasonal variation, clinical manifestations and assessment of the 
improvement in the prognosis of the disease with the trial drug.  
  In Siddha System, it is necessary to bring the vitiated humours to equilibrium. Hence 
before the treatment Meganatha Kulikai with Inji charu (Zingiber officinale) juice was given 
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for Viresanam (Purgation) in the early morning to normalize the vitiated humours. During the 
treatment, the patients were advised to follow pathiyam (Dietary regimen).  
 Internal Drug : Thirutharakchatha chooranam - 2gm two times per day with ghee     
External Drug : Aruganver Thylam for oil bath 2 times per week             
Duration of Drug : 48 days  
  30 patients were enrolled for this study, among 30 patients, age group 20 to 25 years 
were in number 5 (16.6%), patients between 26 to 35 were in number 17 (56.6 %), patients 
between 36 to 45 years were in number 7 (23.3 %), patients between 45 to 55 years, 1 (3.3%).
 Viyagula unmatham commonly appears at young and middle age. In this present study, 
considerable numbers of patients were reported (17 patients) between the age of 26-35 among 
study sample.  
 Among the 30 patients, male cases were reported in number 17(56.6%) and female 
cases were reported in number 13(43.3%). Usually the studies carried out on depression, proves 
that female were affected more than male. But the study revealed that, the occurrence more in 
male than the female due to social stigma and lack of awareness on mental health and cultural 
practice in the sociaty. 
  The majority of patients in this study were common workers 15 (50 %), homemakers 
9(30%), unemployed 4(13.3%) and students 2(6.6%). Inference of this study shows that, in 
current scenario employed people are highly exposed to stress often, which is the root cause of 
depressive disorders. 
  The most of patients in this study were Non-vegetarian 27 (90%) remaining 3 (10%) 
patients were vegetarian. Inference of this study, shows that people who are consuming high 
non-vegetarian diet, gets aggressive behaviour which leads to psychiatric disorders. 
   In this present study shows, considerable numbers of patients were reported from 
neithal (26 patients), marutham (4 patients).  
 Highest number of patients 14 (46.6%) were studied during Pinpani Kaalam, 12 
patients (40%) were studied during Munpani Kaalam, 3 patients (10%) were studied during 
Koothir kaalam and 2 patients were studied during Ilavenil kaalam.   
 Most of patients 9(30%) were affected in duration of below one year and above 2 to 3 
years, 8 (26.6%) patients were affected by the illness from 1 to 2 years, above 3   years were in 
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same number 5 (12.5%). Laboratory investigations were done for all the cases before and after 
treatment. There were no variations in hepatic, renal and other parameters.  
  Among the 30 patients randomized selected 15 patients 
(2,5,7,8,10,13,14,18,19,21,23,26,27,29,30)  received yogam along with   trial medicines 
(internally & externally). This yogam results shown 6 patients (40% %) is good improvement, 
7 patients (46.66%) shown moderate improvement and 2 patients(13.3%)shown mild 
improvement. Patients who have lot of sadness, lack of concentration and sleep exposed to 
very poor result and respond, may be this is the effect of thookkaminmai (Insomnia) and more 
stressful life style. Based on Siddha Literature the one who not maintain the Naal ozhukkam 
(Daily regimen) haven’t maintain their good health, this may reflect in this patient.   
Remaining 15 patients received only trial medicines (Internally & Externally), without 
yogam. This trial medicine shown results as 4 patients(26.66%)shown good improvement and 
9 patients(60%) shown moderate improvement and 2 patients (13.3%) shown mild 
improvement. 
The outcome of this study was clinically observed by HAM-D Score, which showed 
encouraging results of good improvement in 10 patients (33.3%), moderate improvement in 16 
patients (53.3%) and mild improvement in 4 cases (13.3%). 
Patients who were received both treatments (yogam & trial medicine) had revealed 
good result and better revealment than the trial medicine taken alone. Based on this it is shown 
Medicine combined with Yogam therapy is more effective and appropriate to treat the Viyagula 
Unmatham (Depression).  
In this study, no adverse events were observed during the course of the treatment. After 
the study period, all the patients were advised to attend Out Patient Department of Sirappu 
Maruthuvam of NIS for further follow-up of 6 months.  
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    SUMMARY  
The disease Viyagula Unmatham was taken for the clinical study with 
Thirutharakchatha chooranam as internal medicine and Aruganver Thylam for external 
application for oil bath 2 times per week, for the clinical study, 30 cases were selected based 
on the approved protocol.  
The raw drugs were authenticated by the competent authority Medicinal Botany and 
Gunapadam dept, Botanical Authentication Certificate no: NISMB3382018. 
This study has been approved by IEC of NIS [Date of IEC Approval& its number: 
NIS/IEC/2016/11-12/14.10.2016]. The study is safely executed on patients and there were no 
adverse drug reactions noted during the study period and further registered Clinical Trail 
Registry of India [REG. NO. CTRI/2018/04/013421]. 
  Out of 30 cases treated at OPD, of Ayothidoss Pandithar Hospital of National Institute 
of Siddha, Chennai-47. Randomly selected 15 cases(2,5,7,8,10,13,14,18,19,21,23,26,27,29,30)   
were received Yogam therapy. The detailed study on Viyagula unmatham with reference to its 
aetiology, pathogenesis, investigations, clinical features, diagnosis and treatment with trial 
drugs was done.   
  The results were observed by HAM-D score. Among the 30 cases treated, 33.3 % cases 
had shown good improvement,53.3 % cases had shown moderate improvement and 13.3% 
cases had shown mild improvement. Randomised selected 15 patients were received 
additionally Yogam therapy. This revealed 80% of the patients showed more than 50% 
improvement. Combined trial medicine and yogam therapy shown more significant 
improvements. 
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                   CONCLUSION 
 The present clinical study confirms the efficacy of the trial drug Thirutharakchatha 
chooranam (internal medicine) and Aruganver thylam (external medicine) which is Siddha 
poly herbal formulation. It was found to be better resulting on Viyagula unmatham patients in 
reducing clinical symptoms like depressive mood, loss of sleep and appetite, weight loss, lack 
of concentration, anhedonia, suicidal thoughts etc.  The literature evidence for this drug 
Agathiyar Vaithiya Ratna Surukam page no 45, Publication of Tanjavur Magaraja Sarabojini 
Saraswathy   Mahal Noolagam. The quantitative outcome of HAM-D score shows significant 
reduction between before and after treatment. The qualitative outcome shows there is 33.3 % 
of cases had shown good improvement and the rest 53.3 % of cases had shown moderate 
improvement and 13.3% of cases mild improvement. Further the Yogam had shown more 
impressive result of reduction of symptoms of Viyagula unmatham (Depression). It shows the 
better improvement more than 50 % was 26 (86.6 %) patients.        
 According to this result it could be observed that yogam therapy is further given as 
support to improve the condition of Viyagula unmatham (Depression). The Modern Medical 
concept of Anxiety related somatic complaints or Culture bound syndrome also has to be 
proven. The clinical trial conducted in selected patients was satisfactory and the results were 
encouraging. However, a study with large number of patients is required to find out the ideal 
dose response. 
The costs of the trial medicines are comparatively low. The trail medicines are cost 
effective.   
  From the above results, the trial drugs “Thirutharakchatha chooranam” (Internal 
Medicine) and “Aruganver Thylam” (External Medicine) are responded well in the treatment 
of Viyagula unmatham.  
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        NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
  
 
COMPARATIVE CLINICAL STUDY OF  THIRUTHARAKCHATHA CHOORANAM 
(INTERNAL), ARUGANVER THYLAM (EXTERNAL) IN THE TREATMENT  OF 
VIYAGULA UNMATHAM (DEPRESSION) WITH AND WITHOUT YOGAM 
THERAPY 
 Principal Investigator: Dr.S.Siva josyaa                            
SCREENING & SELECTION PROFORMA 
1. SERIAL NO: ……………………………. 2. OP /IP NO: ……………………                              
3. NAME: ……………………………………      4. AGE/GENDER: …………........  
5. OCCUPATION: ………………………….       6. INCOME: ……………………. 
 
INCLUSION CRITERIA 
Age: between 20 years and 55 years Yes/No 
Sex: Both male and female Yes/No 
Depressed mood Yes/No 
Reduced level of interest Yes/No 
Considerable loss or gain of weight Yes/No 
Insomnia or hypersomnia Yes/No 
Psychomotor agitation or retardation Yes/No 
Fatigue Yes/No 
Thoughts of extreme guilt Yes/No 
Diminished ability to think or concentrate Yes/No 
Suicidal thoughts Yes/No 
Willing to participate in trial and signing consent by fulfilling the conditions 
of proforma                       
Yes/No 
Willing to give blood sample for analysis for laboratory investigations Yes/No 
 
          If 8 - 10 criteria are positive, the patients will be included for the study. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
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EXCLUSION CITERIA: 
           Pregnancy and lactation Yes/No 
Diabetes mellitus Yes/No 
Psychosomatic disorders Yes/No 
Cardiac disease Yes/No 
Any other serious systemic illness Yes/No 
 
TRIAL 
YES  NO  
If Yes, OPD  IPD  
  Serial NO:  
 
Date:        
Station: 
 
Signature of the Investigator: 
 
Signature of the Lecturer:                                                           Signature of the HOD   
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      NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
COMPARATIVE CLINICAL STUDY OF THIRUTHARAKCHATHA CHOORANAM 
(INTERNAL), ARUGANVER THYLAM (EXTERNAL) IN THE TREATMENT OF 
VIYAGULA UNMATHAM (DEPRESSION) WITH AND WITHOUT YOGAM 
THERAPY 
 Principal Investigator: Dr.S.Siva josyaa                            
FORM II-A – HISTORY TAKING PROFORMA 
 
STUDY NO:   OP / IP NO: 
 
NAME: AGE / GENDER: 
 
ADDRESS: CONTACT NO: 
 
 RELIGION:  H / C / M / O. 
 
OCCUPATION: INCOME: 
 
MARITAL STATUS:       1. Married 2. Unmarried 
 
DATE OF INTIAL ASSESSMENT:  
 
COMPLAINTS & DURATION:  
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PERSONAL HISTORY: 
 
PERSONAL HABITS YES NO 
IF YES 
SPECIFY 
DURATION 
AMOUNT 
Smoking     
Tobacco Chewing     
Alcohol     
Narcotic Drug Addiction     
  
HISTORY OF PREVIOUS ILLNESS AND TREATMENT TAKEN: 
FAMILY HISTORY:  
Whether this problem runs in family? 1. Yes            2. No    
 
 
If yes, mention the relationship of affected 
person(s) 
1._________________ 
 
2._________________ 
 
DIETARY STYLE: 1. Vegetarian    2. Non-vegetarian 
 
 
MENSTURAL AND OBSTETRIC HISTORY: 
 
 
 
FORM II B  
S.NO GENERAL EXAMINATION    BEFORE 
TREATMENT                                                         
AFTER 
TREATMENT 
1 Body weight [Kg]      
2 Height [cms]                                    
3 Body Temperature [F]         
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4 Blood Pressure (mm/Hg)    
5 Pulse Rate /min   
6 Heart Rate / min   
7 Respiratory Rate /min.   
8 Pallor   
9 Jaundice   
10 Clubbing   
11 Cyanosis   
12 Pedal Oedema   
13 Lymphadenopathy   
14 Jugular venous pulsation   
SYSTEMIC EXAMINATION 
 
  
1 Cardiovascular system   
2 Respiratory system    
3 Gastro-intestinal system   
4 Central Nervous system   
5 Urogenital system   
6 Endocrine system    
 
                                          SIDDHA SYSTEM OF EXAMINATION 
1. THEGI (BODY CONSTITUTION): 
1. Vatha udal                                                                             
2. Pitha udal 
3. Kaba udal 
4. Thontha udal 
2. NILAM (LAND WHERE THE PATIENT LIVED MOST):  
1. Kurinji (Hilly terrain) 
2. Mullai (Forest range) 
3. Marutham (Plains) 
4. Neithal (Coastal belt) 
5. Paalai (Aridregion) 
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3. KAALAM: 
1. Kaar kaalam    (Aavani-Purattasi) 
2. Koothir kaalam     (Ippasi-Kaarthigai) 
3. Munpani kaalam     (Maargazhi-Thai) 
4. Pinpani kaalam       (Maasi-Panguni) 
5. Ilavenil kaalam        (Chithirai-Vaigasi) 
6. Muthuvenil kaalam (Aani-Aadi) 
 
4. GUNAM: 
1. Sathuvam  
2. Rasatham 
3. Thamasam 
5. PORIPULANGAL (SENSORY ORGANS):  
                   
 
 
 
 
 
 
6.KANMENDRIYAM (MOTOR ORGANS) : 
        
 
 
 
 
 
 
 
 
 
 
 Before treatment After treatment 
Mei (Skin) Normal  / Affected Normal  / Affected 
Vai (Tongue) Normal  / Affected Normal  / Affected 
Kann (Eye) Normal  / Affected Normal  / Affected 
Mooku (Nose) Normal  / Affected Normal  / Affected 
Sevi (Ear) Normal  / Affected Normal  / Affected 
 Before treatment After treatment 
Kai (Upper limb) Normal  /Affected Normal  /Affected 
Kaal (Lower 
limb) 
Normal  /Affected Normal  /Affected 
Vai (Oral cavity)   Normal  /Affected Normal  /Affected 
Eruvai (Anal 
region) 
Normal  /Affected Normal  /Affected 
Karuvai (Uro-
Genital region)  
Normal  /Affected Normal  /Affected 
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7. KOSANGAL (SHEATH):    
             
 
 
  
  
8. SEVEN UDAL THAATHUKKAL (SEVEN SOMATIC COMPONENTS) 
 
 Before treatment After treatment 
Saaram Normal  /Affected Normal  /Affected 
Senneer  Normal  /Affected Normal  /Affected 
Oon Normal  /Affected Normal  /Affected 
Kozhuppu Normal  /Affected Normal  /Affected 
Enbu Normal  /Affected Normal  /Affected 
Moolai Normal  /Affected Normal  /Affected 
Sukkilam / Suronitham Normal  /Affected Normal  /Affected 
 
9. UYIR THAATHUKKAL: [THREE HUMORS] (VALI/ AZHAL/ IYYAM) 
A) VALI 
 
 1st day 
8th 
day 
15th 
day 
22nd 
day 
29th 
day 
36th 
day 
43rd 
day 
49th 
day 
Praanan         
Abaanan         
Samaanan         
Udhaanan         
Viyaanan         
Naagan         
 Before treatment After treatment 
Annamaya kosam Normal  /Affected Normal  /Affected 
Pranamaya kosam  Normal  /Affected Normal  /Affected 
Manomaya kosam  Normal  /Affected Normal  /Affected 
Vignanamaya kosam  Normal  /Affected Normal  /Affected 
Ananthamaya kosam Normal  /Affected Normal  /Affected 
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Koorman         
Kirukaran         
Devathathan         
Dhananjeyan         
B) AZHAL 
 
 1st day 8th day 
15th 
day 
22nd 
day 
29th 
day 
36th 
day 
43rd 
day 
49th 
day 
Analakam         
Ranjakam          
Saathakam          
Prasakam          
Aalosakam         
 
C) IYYAM 
 
 1st day 
8th 
day 
15th 
day 
22nd 
day 
29th 
day 
36th 
day 
43rd 
day 
49th 
day 
Avalambagam         
Kilethagam         
Pothagam         
Tharpagam         
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Santhigam         
 
10. ENVAGAI THERVU: [EIGHT TYPES OF EXAMINATION] 
 
I. NAADI: [PULSE PERCEPTION] 
 
NAADI 1st day 
8th 
day 
15th 
day 
22ndday 29thday 
36th  
day 
43rdday 49thday 
         
 
II. SPARISAM: [PALPATION] 
 
Day SPARISAM 
1st day  
8th day  
15th  day  
22nd  day  
29th  day  
36th  day  
43rd day  
49th day  
 
III. NAA: [TONGUE] 
 
NAA 1st day 8thday 15thday 22ndday 29thday 36thday 43rdday 49thday 
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IV. NIRAM: [COMPLEXION]   
      1. Vadham         
      2. Pitham  
      3. Kabam  
 
V. MOZHI: [VOICE] 
      1. High Pitched 
      2. Low Pitched 
      3. Medium Pitched 
VI.VIZHI: [EYES] 
VIZHI 1st day 8th day 15thday 22ndday 29thday 36th  day 43rdday 49thday 
         
VII. MALAM: [BOWEL HABITS / STOOLS] 
 Before treatment After treatment 
Niram   
Irugal   
Ilagal   
Others   
 
VIII. MOOTHIRAM [URINE EXAMINATION] 
NEERKKURI: 
Neerkkuri Before treatment After treatment 
Niram   
Manam   
Edai   
Nurai   
Enjal   
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NEIKKURI:  
Neikkuri Before treatment After treatment 
Aravana neendathu/ 
Snake like pattern 
 
  
Azhipol paraviyathu 
Annular/Ringed pattern 
 
 
 
parav paraparavoiyadu 
  
Muththothu ninrathu  
Pearl beaded pattern 
  
Other patterns   
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                           Signature of the HOD 
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      NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
COMPARATIVE CLINICAL STUDY OF THIRUTHARAKCHATHA CHOORANAM 
(INTERNAL), ARUGANVER THYLAM (EXTERNAL) IN THE TREATMENT  OF 
VIYAGULA UNMATHAM (DEPRESSION) WITH AND WITHOUT YOGAM 
THERAPY. 
Principal Investigator : Dr.S.Siva josyaa                            
1. SERIAL NO:      2. OP /IP NO:                              
3. NAME:            4. AGE/GENDER: 
 
 
FORM-III - LABORATORY INVESTIGATIONS 
 
 
BLOOD INVESTIGATION 
 
NORMA
L 
VALUES 
BEFORE 
TREATMENT 
(WITH 
DATE) 
AFTER 
TREATMENT 
(WITH DATE) 
 
Hb( gm/dl) 
M:12-15 
W:11.5-14 
  
 
T.WBC (cells/cu.mm) 
4000-
11000 
  
DIFFERENTIAL 
COUNT (%) 
Polymorphs 40-75   
Lymphocytes 20-40   
Monocytes 2-10   
Eosinophils 1-6   
Basophils 0-1   
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T.RBC(million cells/cu.mm) 
 
M:4.0-5.5 
 W:3.5-4.5 
 
 
 
 
 
  ESR(mm/hour) ½ hr. M:6-12 
W:7-18 
  
 
 
 1 hr.   
Blood Investigations Normal Values 
Before Treatment 
(WITH DATE) 
After Treatment 
(WITH DATE) 
Blood glucose 
(mg/dl) 
Fasting 
   
 70-110 
 
  
PP 
 
   80-140 
 
  
Random 
   
 80-120 
 
  
RFT (mg/dl) 
Blood 
urea 
    
16-50 
 
  
 
Serum 
creatinin
e 
   0.6-1.2   
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LFT (mg/dl) 
 
 
 
 
Total 
bilirubin 
   
 0.2-1.2 
  
Direct 
bilirubin 
   
 0.1-1.2 
  
Indirect 
bilirubin 
   
 0.2-0.7 
 
  
 
SGOT  
    
0-40 
  
SGPT  
   
 0-35 
  
Alkaline 
phospha
tase 
 80-290   
RA FACTOR     
CRP     
ASO TITRE     
THYROID 
PROFILE 
T3 1.95- 5.40pg/ml   
 TSH 0.25- 5µIU/ml   
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Date:          
Station: 
 
Signature of the Investigator: 
 
Signature of the Lecturer:                                                             Signature of the HOD 
 
 
 
 
 
 
 
 
Urine investigation Before Treatment (with Date) After Treatment (With Date) 
Neerkuri   
Niram   
Edai   
Manam   
Nurai   
Enjal   
Neikuri   
Albumin   
Fasting sugar   
PP sugar   
Deposits 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
COMPARATIVE CLINICAL STUDY OF THIRUTHARAKCHATHA CHOORANAM 
(INTERNAL), ARUGANVER THYLAM (EXTERNAL) IN THE TREATMENT OF 
VIYAGULA UNMATHAM (DEPRESSION) WITH AND WITHOUT YOGAM 
THERAPY   
Principal Investigator: Dr.S.Siva josyaa                            
FORM –VI- DRUG COMPLIANCE FORM 
SERIAL NO:                                                                                                      
NAME:  
DRUG NAME:  
On 1st     day-Date: Drugs issued: (gms) Drugs returned:    (gms) 
On 8th   day-Date:  Drugs issued: (gms) Drugs returned:    (gms) 
On 15th day-Date:       Drugs issued: (gms) Drugs returned:    (gms) 
On 22th day-Date:       Drugs issued: (gms) Drugs returned:    (gms) 
On 29th day-Date:       Drugs issued: (gms) Drugs returned:    (gms) 
On 36th day-Date:       Drugs issued: (gms) Drugs returned:    (gms) 
On 43th day-Date:       Drugs issued: (gms) Drugs returned:    (gms) 
   Day    Date          Morning   Evening   Day    Date    Morning   Evening 
Day 1    Day25    
Day2    Day26    
Day3    Day27    
Day4    Day28    
Day5    Day29    
Day6    Day30    
Day7    Day31    
Day8    Day32    
Day9    Day33    
Day10    Day34    
Day11    Day35    
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Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                          Signature of the HOD 
 
 
 
 
 
 
 
 
 
 
 
Day12    Day36    
Day13    Day37    
Day14    Day38    
Day15    Day39    
Day16    Day40    
Day17    Day41    
Day18    Day42    
Day19    Day43    
Day20    Day44    
Day21    Day45    
Day22    Day46    
Day23    Day47    
Day24    Day 48    
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
COMPARATIVE CLINICAL STUDY OF THIRUTHARAKCHATHA CHOORANAM 
(INTERNAL), ARUGANVER THYLAM (EXTERNAL) IN THE TREATMENT OF 
VIYAGULA UNMATHAM (DEPRESSION) WITH AND WITHOUT YOGAM 
THERAPY 
Principal Investigator : Dr.S.Siva josyaa                            
                                 FORM V– PATIENT INFORMATION SHEET 
Name of Principal Investigator: Dr.S.Siva josyaa 
Guide: Dr.N.J.Muthukumar 
Name of the institute: National Institute of Siddha, 
                                      Tambaram Sanatorium, Chennai-47. 
 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE CLINICAL 
TRIAL. 
       I, Dr.S.Siva josyaa studying M.D (Siddha) at National Institute of Siddha, Tambaram 
Sanatorium is doing a trial on ‘VIYAGULA UNMATHAM (DEPRESSION). It is a most 
common dermatological problem, occurring throughout the world. In this regard, I am in a need 
to ask you few questions. I will maintain confidentiality of your comments and data obtained. 
There will be no risk of disclosing your identity and no physical, psychological or professional 
risk is involved by taking part in this study. Taking part in this study is voluntary. No 
compensation will be paid to you for taking   part in this study. 
           You can choose not to take part. You can choose not to answer a specific question. There 
is no specific benefit for you if you take part in the study. However, taking part in the study 
may be of benefit to the community, as it may help us to understand the problem of defaulters 
and potential solutions. 
             If you agree to be a participant in this study, you will be included in the study primarily 
by signing the consent form and then you will be given the internal medicine 
“THIRUTHARATCHATHA CHOORANAM (INTERNAL MEDICINE), 2gm bds, 
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ARUGANVER THYLAM (EXTERNAL MEDICINE) for 48 days. The information I am 
collecting in this study will remain between you and the principal investigator (myself). I will 
ask you few questions through a questionnaire. I will not write your name on this form. Ur 
name won’t be mentioned in the lab investigation form instead a code will be used. 
The questionnaire will take approximately 20 minutes of your time. 
 If you want to know more about this study before taking part, you can ask me all the 
questions you want or contact Dr.S.SIVA JOSYAA, PG Scholar cum principal investigator of 
this study, National Institute of Siddha, Chennai-47, Ph no 9677454003. You can also contact 
the Member-secretary of Ethical committee, National Institute of Siddha, Chennai 600047, 
Tel.No: 91-44-22380789, for rights and participation in the study.                         
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
COMPARATIVE CLINICAL STUDY OF THIRUTHARAKCHATHA CHOORANAM 
(INTERNAL), ARUGANVER THYLAM (EXTERNAL) IN THE TREATMENT  OF 
VIYAGULA UNMATHAM (DEPRESSION) WITH AND WITHOUT YOGAM 
THERAPY. 
Principal Investigator : Dr.S.Siva josyaa                            
FORM-V  –  INFORMED CONSENT FORM 
“I have read the foregoing information, or it has been read to me. I have had the 
opportunity to ask questions about it and any questions I have asked have been answered to 
my satisfaction.  
            I consent voluntarily to participate as a participant in this study and understand that 
I have the   right to withdraw from the study at any time without in any way it affecting my 
further medical care”. 
"I have received a copy of the information sheet/consent form". 
Date:  
Signature of the participant 
In case of illiterate participant 
        “I have witnessed the accurate reading of the consent form to the potential participant, 
and the individual has had the opportunity to ask questions. I confirm individual has given 
consent freely.”                                                   
Date: 
Signature of a witness  
(Selected by the participant bearing no connection with the survey team)   
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Left thumb Impression of the Participant 
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     NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
. 
COMPARATIVE CLINICAL STUDY OF THIRUTHARAKCHATHA CHOORANAM 
(INTERNAL), ARUGANVER THYLAM (EXTERNAL) IN THE TREATMENT  OF 
VIYAGULA UNMATHAM (DEPRESSION) WITH AND WITHOUT YOGAM 
THERAPY. 
Principal Investigator : Dr.S.Siva josyaa                            
FORM VII -A- WITHDRAWAL FORM 
 
1. SERIAL NO OF THE CASE: …………………   
2. OP / IP NO: ......................................    
3. NAME: ………………………     
4.AGE: …………        
5.GENDER:...........                           
6. DATE OF TRIAL COMMENCEMENT: ………………... 
7. DATE OF WITHDRAWAL FROM TRIAL: …………….. 
8. REASONS FOR WITHDRAWAL: 
Long absence at reporting:               Yes/ No 
Irregular treatment:                           Yes/ No 
Shift of locality:                                     Yes/No 
Increase in severity of symptoms:     Yes/No 
Development of severe adverse drug reactions:   Yes/No 
Development of adverse event:                                              Yes/No 
(If YES, give the details of adverse reaction in Form VII -B – Adverse 
Reaction Form / Pharmaco Vigilance Form) 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                          Signature of the HOD 
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DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
COMPARATIVE CLINICAL STUDY OF THIRUTHARAKCHATHA CHOORANAM 
(INTERNAL), ARUGANVER THYLAM (EXTERNAL) IN THE TREATMENT  OF 
VIYAGULA UNMATHAM (DEPRESSION) WITH AND WITHOUT YOGAM 
THERAPY. 
Principal Investigator : Dr.S.Siva josyaa                            
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THE HAMILTON  RATING  SCALE  FOR  DEPRESSION 
SERIAL NO: 
OP/IP NO 
NAME     AGE:   GENDER: 
To rate the severity of depression in patients who are already diagnosed as depressed, 
administer this questionnaire. The higher the score, the more severe the depression. 
For each time, write the correct number on the line next to the item. (Only one response 
per item)    
1.DEPRESSED MOOD (Sadness, hopeless, helpless, worthless) 
0 = Absent 
1 = These feeling states indicated only on questioning         
2 = These feeling states spontaneously reported verbally 
3 = Communicates feeling states non- verbally- i.e., through facial expression,  
      posture, voice and tendency to weep 
4 = Patient reports virtually only these feeling states in his spontaneous verbal and    
      non verbal communication 
2.FEELINGS OF GUILT 
0 = Absent 
1 = Self reproach, feels he has let people down 
2 = Ideas of guilt or rumination over past errors or sinful deeds        
3 = Present illness is a punishment. Delusions of guilt 
4 = Hears accusatory or denunciatory voices and/ or experiences threatening visual  
      hallucinations 
3.SUICIDE 
0= Absent 
1= Feels life is not worth living            
2= Wishes he were dead or any thoughts of possible death to self 
3= Suicidal ideas or gesture 
4= Attempts at suicide ( any serious attempt rates 4) 
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4.INSOMIA EARLY              
0= No difficulty falling asleep              
1= Complaints of occasional difficulty falling asleep- i.e., more than ½ hour 
2= Complaints of nightly difficulty falling asleep 
5.INSOMIA MIDDLE 
0 = No difficulty falling asleep     
1 = Patient complaints  of being restless and disturbed during the night  
2 = Walking during the night – any getting out of bed rates 2 ( except for purposes of  
      voiding) 
6.INSOMIA LATE 
0= No difficulty 
1= Waking in early hours of the morning but goes back to sleep 
2= Unable to fall asleep again if he gets out of bed 
7.WORK AND ACTIVITIES 
0 = No difficulty 
1 = Thoughts and feelings of incapacity, fatigue or weakness related to activities: 
work or hobbies 
2 = Loss of interest in activity: hobbies or work- either directly reported by patient or 
indirect in listlessness, indecision and vacillation ( feels he has to push self to   work or 
activities) 
3= Decrease in actual time spent in activities or decrease in productivity 
4=Stopped working because of present illness 
8.RETARDATION: PSYCHOMOTOR (Slowness of thought and speech: impaired  
ability to concentrate: decreased motor activity) 
0= Normal speech and thought 
1= Slight retardation at interview 
2= Obvious retardation at interview 
3= Interview difficult 
4= Complete stupor 
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9.AGITATION 
0= None 
1= Fidgetiness 
2= Playing with hands, hair, etc 
3= Moving about, can’t sit still 
4= Hand wringing, nail biting, hair pulling, biting of lip 
10.ANXIETY ( PSYCHOLOGICAL) 
0= No difficulty 
1= Subjective tension and irritability 
2= Worrying about minor matters 
3= Apprehensive attitude apparent in  face or speech 
4= Fears expressed without questioning 
11.ANXIETY SOMATIC: Physiological concomitants of anxiety, (i.e., effects of autonomic 
overactivity, “butterflies,” indigestion, stomach cramps, belching, diarrhoea, palpitations, 
hyperventilation, paresthesia, sweating, flushing, tremor, headache, urinary frequency).Avoid 
asking about possible medication side effects(i.e., dry mouth, constipation) 
0 = Absent 
1 = Mild 
2 = Moderate 
3 = Severe 
12.SOMATIC SYMPTOMS (GASTROINTESTINAL) 
0 = None 
1 = Loss of appetite but eating without encouragement from others. Food intake about  
normal 
2 = Difficulty eating without urging from others. Marked reduction of appetite and  
      food Intake 
13.SOMATIC SYMPTOMS GENERAL 
0 = None 
1 = Heaviness in limbs, back or head. Backaches, headache, muscle aches. Loss of  
energy and fatigability 
2= Any clear- cut symptom rates 2 
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14.GENITAL SYMPTOMS (Symptoms such as: loss of libido; impaired sexual 
performance; menstrual disturbances) 
0= Absent 
1= Mild 
2= Severe 
15.HYPOCHONDRIASIS 
0= Not present 
1= Self – absorption (bodily) 
2= Preoccupation with health 
3= Frequent complaints, requests for help, etc 
4= Hypochondrial delusions 
16.LOSS OF WEIGHT 
A. When rating by history: 
0 = No weight loss 
1 = Probably weight loss associated with present illness 
2 = Definite( according to patient) weight loss 
17.INSIGHT 
0 = Acknowledges being depressed and ill 
1 = Acknowledges illness but attributes causes to bad food, climate, overwork, virus,  
      need for rest, etc. 
2= Denies being ill at all 
18.DIURNAL VARIATION 
A. Note whether symptoms are worse in morning or evening. If NO diurnal variation, mark 
none 
0 = No variation 
1 = Worse in A.M. 
2 = Worse in P.M. 
B. When present, mark the severity of the variation. Mark “None” if NO variation 
0= None 
1= Mild 
2=Severe 
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19.DEPERSONALIZATION AND DECREALIZATION (Suchas: Feelings of unreality: 
Nihilistic ideas) 
0 = Absent 
1 = Mild 
2 = Moderate 
3 = Severe 
20.PARANOID SYMPTOMS 
0= None 
 1= Suspicious 
2= Ideas of reference 
3= Delusions of reference and persecution 
21.OBSESSIONAL AND COMPULSIVE SYMPTOMS 
0 = Absent 
1 = Mild 
2 = Severe 
        Total score __________ 
HAM- D Scoring Instructions: 
Sum the scores from the first 17 items. 
0-7  = Normal 
8-13  = Mild Depression 
14-18  = Moderate Depression 
19-22  = Severe Depression 
≥ 23   = Very Severe Depression 
                                                                   
 
Date: 
Station: 
Signature of the Investigator: 
Signature of the Lecturer:      Signature of the HOD 
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600047
India
Phone 9444206843
Fax
Email njmuthu@hotmail.com
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Source of Monetary or
Material Support
Source of Monetary or Material Support
> National Institute Of Siddha Tambarum sanatorium kancheepuram
Primary Sponsor Primary Sponsor Details
Name Ayothidoss Pandithar Hospital
Address National Institute of Siddha Tambaram sanatorium Chennai 47
Type of Sponsor Research institution and hospital
Details of Secondary
Sponsor
Name Address
NIL NIL
Countries of
Recruitment
List of Countries
India
Sites of Study Name of Principal
Investigator 
Name of Site Site Address Phone/Fax/Email
Dr S Siva josyaa National Insititute of
Siddha
Tambaram sanatorium
Chennai 47
Kancheepuram
TAMIL NADU
9677454003
drjosyaaselvam93@gm
ail.com
Details of Ethics
Committee
Name of Committee Approval Status Date of Approval Is Independent Ethics
Committee?
National Institute of
Siddha
Approved 14/10/2016 Yes
Regulatory Clearance
Status from DCGI
Status Date
Not Applicable No Date Specified
Health Condition /
Problems Studied
Health Type Condition
Patients PEOPLE IN DEPRESSED MOOD BUT
SHOULD BE IN GOOD ORIENTATION
Intervention /
Comparator Agent
Type Name Details
Intervention Thirutharakchatha chooranam
internally and Aruganver thylam
externally
Thirutharakchatha chooranam 2
gm twice a day with Ghee Q S
and Aruganver thylam for oil
bath twice a week for 48 days
Comparator Agent yogam 1 pranayamam 2 santhi asanam
3 bhavana mukthasanam 4
sarvangasanam 5 surya
namaskaram patients should
practice these yogasanams for
48 days.
Inclusion Criteria Inclusion Criteria
Age From 20.00 Year(s)
Age To 55.00 Year(s)
Gender Both
Details 1 Depressed mood
2 Reduced level of interest
3 Considerable loss or gain of weight
4 Insomnia or hypersomnia
5 Psychomotor agitation or retardation
6 Fatigue
7 Thoughts of extreme guilt
8 Diminished abilty to think or concentrate
9 Suicidal thoughts
10 Willing to participate in trial and signing consent by fulfilling the
conditions of proforma
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11 Willing to give blood sample for analysis for laboratory
investigations
Exclusion Criteria Exclusion Criteria
Details 1 Pregnancy and lactation
2 diabetes mellitus
3 psychosomatic disorder
4 cardiac diseases
5 any other systemic illness
Method of Generating
Random Sequence
Not Applicable
Method of
Concealment
Case Record Numbers
Blinding/Masking Open Label
Primary Outcome Outcome Timepoints
Reduction in the symptoms of Depression. 45 days
Secondary Outcome Outcome Timepoints
To enhance the good health. 48 days
Target Sample Size Total Sample Size=30
Sample Size from India=30
Phase of Trial Phase 2
Date of First
Enrollment (India)
25/04/2018
Date of First
Enrollment (Global)
No Date Specified
Estimated Duration of
Trial
Years=1
Months=0
Days=0
Recruitment Status of
Trial (Global)
Not Applicable
Recruitment Status of
Trial (India)
Not Yet Recruiting
Publication Details not yet
Brief Summary A depressive disorder is a syndrome (group of symptoms) that
reflects a sad and/or irritable mood exceeding normal sadness or grief.
More specifically, the sadness of depression is characterized by a greater
intensity and duration and by more severe symptoms and functional
disabilities than is normal.
Depressive disorders are a huge public-health problem, due to its
affecting millions of people. About 10% of adults, up to 8% of teens and
2% of preteen children experience some kind of depressive disorder.
 Siddha system of medicine has mentioned a lot about Mana noigal
like Madha azivu, Madha noi, Kirigai, Unmadham. Siddhars also had
mentioned about the treatment aspects for Mana noigal. The symptoms of
mana noigal include hallucinations, lack of interest in all activities, fatigue,
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depressed mood, insomnia etc.
This is the largest population-based study from India to report on
prevalence of depression and shows that among urban south Indians, the
prevalence of depression was 15.1%. Age, female gender and lower
socio-economic status are some of the factors associated with depression
in this population. The overall prevalence of depression was 15.1%
(age-adjusted, 15.9%) and was higher in females (females 16.3% vs.
males 13.9%, p<0.0001). The odds ratio (OR) for depression in female
subjects was 1.20 [Confidence Intervals (CI): 1.12–1.28, p<0.001]
compared to male subjects. Depressed mood was the most common
symptom (30.8%), followed by tiredness (30.0%) while more severe
symptoms such as suicidal thoughts (12.4%) and speech and motor
retardation (12.4%) were less common.   
       Every month, about 7 to 9 patients report to OPD Of Ayothidoss
Pandithar Hospital, National Institute of Siddha, Tambaram sanatorium,
Chennai-47. In the Modern era, Depression is a major problem among
people. We feel that THIRUTHARATCHATHA CHOORANAM AND
ARUGANVER THYLAM will reduce the symptoms of Depression and it is
cost effective too. 
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